
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>Medications for Diabetes Mellitus Treatment - Endocrine and Metabolic Disorders - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "912a66b5-650e-4099-a978-4c78e044364d";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v29299425";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "d4731521-eda3-43b9-936e-bd2cc0b4b883",
 VasontId : "v987978"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "4ea3f68c-a029-4073-a010-f26f493d2d02",
 VasontId : "v878839"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="912a66b5-650e-4099-a978-4c78e044364d">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = 'b5f1464c-b80b-42ce-8c82-c77adedc69f1';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 Medications for Diabetes Mellitus Treatment
 </h1>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/brutsaert-erika.html">Erika F. Brutsaert</a></strong>
 <p class="topic__authors--description">, MD, New York Medical College</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised Oct 2023 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="250;MM806;MM807;MM1073" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v29299466" class="topicmenu_mobile__paragraph">Insulin</a>
 </li>
 <li>
 <a href="#v29299822" class="topicmenu_mobile__paragraph">Oral Antihyperglycemic Medications</a>
 </li>
 <li>
 <a href="#v29300310" class="topicmenu_mobile__paragraph">Injectable Antihyperglycemic Medications</a>
 </li>
 <li>
 <a href="#v84916192" class="topicmenu_mobile__paragraph">Disease-Modifying Medications for Diabetes</a>
 </li>
 <li>
 <a href="#v29300418" class="topicmenu_mobile__paragraph">Adjunctive Medications for Diabetes</a>
 </li>
 <li>
 <a href="#v49788340" class="topicmenu_mobile__paragraph">More Information</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 3D Models (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Calculators (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Images (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Tables (3)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Onset, Peak, and Duration of Action of Human Insulin Preparations*">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Onset, Peak, and Duration...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"fdb08b9a-20e4-4098-9b0d-5cebf828e483","Title":"Onset%2C%20Peak%2C%20and%20Duration%20of%20Action%20of%20Human%20Insulin%20Preparations%2A","ShareUrlTitle":"onset-peak-and-duration-of-action-of-human-insulin-preparations","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56218278","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Onset%2C%20Peak%2C%20and%20Duration%20of%20Action%20of%20Human%20Insulin%20Preparations%2A","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Characteristics of Oral Antihyperglycemics">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Characteristics of Oral Antihyper...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"bf86f264-6945-487c-87d4-c425b6d5b7ff","Title":"Characteristics%20of%20Oral%20Antihyperglycemics","ShareUrlTitle":"characteristics-of-oral-antihyperglycemics","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v84915273","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Characteristics%20of%20Oral%20Antihyperglycemics","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Characteristics of Injectable Non- Antihyperglycemic Medications">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Characteristics of Injectable...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"dc414551-81c5-40f8-9c3b-9db1d1ec857d","Title":"Characteristics%20of%20Injectable%20Non-%20Antihyperglycemic%20Medications","ShareUrlTitle":"characteristics-of-injectable-non-antihyperglycemic-medications","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v84915547","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Characteristics%20of%20Injectable%20Non-%20Antihyperglycemic%20Medications","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v29299457" class="anchor"></span><div class="para"> <p> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html#v988395" data-toggle="tooltip" title="Treatment" data-id="5c907925-48b4-4cac-9c89-1af9c4f0cc97" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">General treatment of diabetes mellitus</a><span id="5c907925-48b4-4cac-9c89-1af9c4f0cc97" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html#v988395"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> for all patients involves lifestyle changes, including diet and exercise. Appropriate monitoring and control of blood glucose levels is essential to prevent <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html" data-toggle="tooltip" title="Complications of Diabetes Mellitus" data-id="afea4eea-6426-4204-a5de-eb68fa563bcf" data-itemid="ec552a1a-fa57-4ab9-a8da-ce820d465c83">complications of diabetes</a><span id="afea4eea-6426-4204-a5de-eb68fa563bcf" class="d-none xref"> <span class="tooltip-container"> <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Complications of Diabetes Mellitus </span> In patients with diabetes mellitus, years of poorly controlled hyperglycemia lead to multiple, primarily vascular, complications that affect small vessels (microvascular), large vessels (macrovascular)... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/9/6/496-cellulitis-with-foot-ulcer-slide-98a-springer-crop-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Complications of Diabetes Mellitus" loading="lazy"> </span> </a> </span> </span>. (See also <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html" data-toggle="tooltip" title="Diabetes Mellitus (DM)" data-id="37beba03-9be0-4766-af5c-2242854df26c" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">Diabetes Mellitus</a><span id="37beba03-9be0-4766-af5c-2242854df26c" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetes Mellitus (DM) </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>.)</p></div><span id="v29299460" class="anchor"></span><div class="para"> <p>Patients with type 1 diabetes mellitus are treated with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>insulin</span> and also benefit from diet and exercise. Analogs of <span class="genericDrug" data-showrollover="false">amylin</span>, another hormone produced by pancreatic beta-cells, may be used as an adjunctive treatment to <span class="genericDrug" data-showrollover="false">insulin</span>. The anti-CD3 monoclonal antibody <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>teplizumab</span> can delay progression to symptomatic type 1 diabetes in patients who are presymptomatic and have mild glucose elevations and autoantibodies. </p></div><span id="v29299462" class="anchor"></span><div class="para"> <p>Patients with type 2 diabetes mellitus are often initially treated with only diet and exercise. If those measures are not sufficient for glycemic control, patients may be prescribed non-<span class="genericDrug" data-showrollover="false">insulin</span> antihyperglycemic medications (eg, injectable <span class="genericDrug" data-showrollover="false">glucagon</span>-like peptide-1 [GLP-1] receptor agonists), <span class="genericDrug" data-showrollover="false">insulin</span>, or a combination of these medications.</p></div><span id="v29299464" class="anchor"></span><div class="para"> <p>Some medications help prevent <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html" data-toggle="tooltip" title="Complications of Diabetes Mellitus" data-id="8aefc675-2cc5-4d16-979e-1ee3b3a604d0" data-itemid="ec552a1a-fa57-4ab9-a8da-ce820d465c83">diabetes complications</a><span id="8aefc675-2cc5-4d16-979e-1ee3b3a604d0" class="d-none xref"> <span class="tooltip-container"> <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Complications of Diabetes Mellitus </span> In patients with diabetes mellitus, years of poorly controlled hyperglycemia lead to multiple, primarily vascular, complications that affect small vessels (microvascular), large vessels (macrovascular)... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/9/6/496-cellulitis-with-foot-ulcer-slide-98a-springer-crop-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Complications of Diabetes Mellitus" loading="lazy"> </span> </a> </span> </span>, including renin-angiotensin-aldosterone system blockers (angiotensin-converting enzyme [ACE] inhibitors or <span class="genericDrug" data-showrollover="false">angiotensin II</span> receptor blockers [ARBs]), statins, and <span class="genericDrug" data-showrollover="false">aspirin</span>.</p></div> <section id="v29299466" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v29299467" class="anchor"></span> <span class="genericDrug" data-showrollover="false">Insulin</span> </h2> <div class="topic__content"> <span id="v29299471" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Insulin</span> is required for all patients with type 1 diabetes mellitus because they do not produce <span class="genericDrug" data-showrollover="false">insulin</span> (due to destruction of the pancreatic beta-cells) and will develop <a href="./{F81143FB-A7CE-4C85-913C-222DEE4C7358}.html" data-toggle="tooltip" title="Diabetic Ketoacidosis (DKA)" data-id="73dae384-b701-44d1-9cbd-e64a9ce7676c" data-itemid="f81143fb-a7ce-4c85-913c-222dee4c7358">ketoacidosis</a><span id="73dae384-b701-44d1-9cbd-e64a9ce7676c" class="d-none xref"> <span class="tooltip-container"> <a href="./{F81143FB-A7CE-4C85-913C-222DEE4C7358}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetic Ketoacidosis (DKA) </span> Diabetic ketoacidosis (DKA) is an acute metabolic complication of diabetes characterized by hyperglycemia, hyperketonemia, and metabolic acidosis. Hyperglycemia causes an osmotic diuresis with... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> without it. <span class="genericDrug" data-showrollover="false">Insulin</span> is also used in the management of many patients with type 2 diabetes. </p></div><span id="v29299472" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> replacement in type 1 diabetes should ideally mimic beta-cell function to provide basal and prandial requirements (physiologic replacement or basal-bolus dosing). To achieve this, different preparations of <span class="genericDrug" data-showrollover="false">insulin</span> and methods of administration can be used. </p></div><span id="v29299481" class="anchor"></span><div class="para"> <p>Except for use of regular <span class="genericDrug" data-showrollover="false">insulin</span>, which is given IV in <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html#v989205" data-toggle="tooltip" title="Hospitalization" data-id="1c68ccba-4db7-486c-8e36-1d6d454c677a" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">hospitalized patients</a><span id="1c68ccba-4db7-486c-8e36-1d6d454c677a" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html#v989205"> <span class="tooltip-content"> <span class="tooltip-heading"> Hospitalization </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <span class="genericDrug" data-showrollover="false">insulin</span> is almost always administered subcutaneously. An inhaled <span class="genericDrug" data-showrollover="false">insulin</span> preparation is also available for patients who prefer not to inject themselves. It has a slightly more rapid onset of action compared to subcutaneously injected rapid acting <span class="genericDrug" data-showrollover="false">insulin</span>.</p></div><span id="v84916083" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> is typically administered as either:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v84916087" class="anchor"></span><div class="para"> <p>Multiple daily subcutaneous injections administered by the patient, with 2 preparations of <span class="genericDrug" data-showrollover="false">insulin</span> used depending on the anticipated glycemic control needs</p></div></li><li class="topic__listitem"><span id="v84916090" class="anchor"></span><div class="para"> <p>An <span class="genericDrug" data-showrollover="false">insulin</span> pump that delivers a rapid- or short-acting <span class="genericDrug" data-showrollover="false">insulin</span> and administers a basal rate of <span class="genericDrug" data-showrollover="false">insulin</span> and additional boluses with meals or for correcting a high blood glucose level</p></div></li></ul></div><span id="v84916094" class="anchor"></span><div class="para"> <p>Both strategies require close attention to diet and exercise as well as to <span class="genericDrug" data-showrollover="false">insulin</span> timing and dose. </p></div><span id="v29299476" class="anchor"></span><div class="para"> <p>When <span class="genericDrug" data-showrollover="false">insulin</span> is needed for patients with type 2 diabetes, glycemic control can often be achieved with basal <span class="genericDrug" data-showrollover="false">insulin</span> combined with non-<span class="genericDrug" data-showrollover="false">insulin</span> antihyperglycemic medications, although some patients may require prandial <span class="genericDrug" data-showrollover="false">insulin</span>. </p></div> <section id="v41829178" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v41829179" class="anchor"></span> <span class="genericDrug" data-showrollover="false">Insulin</span> preparations </h3> <div class="topic__content"> <span id="v41829180" class="anchor"></span><div class="para"> <p>Most <span class="genericDrug" data-showrollover="false">insulin</span> preparations are recombinant human, mostly eliminating the once-common allergic reactions to the medication when it was extracted from animal sources. A number of analogs are also available. These analogs were created by modifying the human <span class="genericDrug" data-showrollover="false">insulin</span> molecule to alter absorption rates and duration and time to action.</p></div><span id="v41829183" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> types are commonly categorized by their time to onset and duration of action (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"fdb08b9a-20e4-4098-9b0d-5cebf828e483","Title":"Onset%2C%20Peak%2C%20and%20Duration%20of%20Action%20of%20Human%20Insulin%20Preparations%2A","ShareUrlTitle":"onset-peak-and-duration-of-action-of-human-insulin-preparations","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56218278","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EOnset%2C%20Peak%2C%20and%20Duration%20of%20Action%20of%20Human%20%3Cspan%20class%3D%27disableDrug%27%20tabindex%3D%270%27%20role%3D%27link%27%20onclick%3D%27javascript%3Avoid%280%29%3B%27%3EInsulin%3C%2Fspan%3E%20Preparations%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). However, these parameters vary within and among patients, depending on many factors (eg, site and technique of injection, amount of subcutaneous fat, blood flow at the injection site).</p></div> <span id="v41829186"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v41829188"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"fdb08b9a-20e4-4098-9b0d-5cebf828e483","Title":"Onset%2C%20Peak%2C%20and%20Duration%20of%20Action%20of%20Human%20Insulin%20Preparations%2A","ShareUrlTitle":"onset-peak-and-duration-of-action-of-human-insulin-preparations","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56218278","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Onset%2C%20Peak%2C%20and%20Duration%20of%20Action%20of%20Human%20Insulin%20Preparations%2A","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="fdb08b9a-20e4-4098-9b0d-5cebf828e483"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'fdb08b9a-20e4-4098-9b0d-5cebf828e483' }, async: true, success: function (data) { $('#fdb08b9a-20e4-4098-9b0d-5cebf828e483').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v41829368" class="anchor"></span><div class="para"> <p><b>Rapid-acting insulins,</b> including lispro and aspart, are rapidly absorbed because reversal of an amino acid pair prevents the <span class="genericDrug" data-showrollover="false">insulin</span> molecule from associating into dimers and polymers. They begin to reduce plasma glucose often within 15 minutes but have short duration of action (<span class='symbol'>&lt</span> 4 hours). These <span class="genericDrug" data-showrollover="false">insulins</span> are best used at mealtime to control postprandial spikes in plasma glucose. Inhaled <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>regular insulin</span> is a rapid-acting <span class="genericDrug" data-showrollover="false">insulin</span> that is taken with meals. It has a slightly more rapid onset of action compared to subcutaneously injected rapid-acting <span class="genericDrug" data-showrollover="false">insulin</span> but dosing is less flexible, and periodic pulmonary examinations are required. </p></div><span id="v41829372" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Regular insulin</span></b> is slightly slower in onset (30 to 60 minutes) than lispro and aspart but lasts longer (6 to 8 hours). It is the only <span class="genericDrug" data-showrollover="false">insulin</span> form for IV use.</p></div><span id="v41829374" class="anchor"></span><div class="para"> <p><b>Intermediate-acting insulins</b> include <span class="genericDrug" data-showrollover="false">insulin</span> isophane (Neutral <span class="genericDrug" data-showrollover="false">protamine</span> Hagedorn, or NPH) and U-500 regular. The onset of action for <span class="genericDrug" data-showrollover="false">insulin</span> isophane is about 2 hours after injection; peak effect is 4 to 12 hours after injection, and duration of action is 18 to 26 hours. Concentrated regular <span class="genericDrug" data-showrollover="false">insulin</span> U-500 has a similar peak and duration of action (peak 4 to 8 hours; duration 13 to 24 hours) and can be dosed 2 to 3 times per day. </p></div><span id="v41829377" class="anchor"></span><div class="para"> <p><b>Long-acting insulins,</b> such as <span class="genericDrug" data-showrollover="false">insulin</span> glargine, <span class="genericDrug" data-showrollover="false">insulin</span> detemir, and U-300 <span class="genericDrug" data-showrollover="false">insulin</span> glargine, unlike <span class="genericDrug" data-showrollover="false">insulin</span> isophane, have no discernible peak of action and provide a steady basal effect over 24 hours. <span class="genericDrug" data-showrollover="false">Insulin</span> degludec (another long-acting <span class="genericDrug" data-showrollover="false">insulin</span>) has an even longer duration of action of over 40 hours. It is dosed daily, and although it requires 3 days to achieve steady state, the timing of dosing is less rigid. </p></div><span id="v41829383" class="anchor"></span><div class="para"> <p><b>Combinations</b> of <span class="genericDrug" data-showrollover="false">insulin</span> isophane and regular <span class="genericDrug" data-showrollover="false">insulin</span> and of <span class="genericDrug" data-showrollover="false">insulin</span> lispro and lispro <span class="genericDrug" data-showrollover="false">protamine</span> (a form of lispro modified to act like <span class="genericDrug" data-showrollover="false">insulin</span> isophane) are commercially available in premixed preparations (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"fdb08b9a-20e4-4098-9b0d-5cebf828e483","Title":"Onset%2C%20Peak%2C%20and%20Duration%20of%20Action%20of%20Human%20Insulin%20Preparations%2A","ShareUrlTitle":"onset-peak-and-duration-of-action-of-human-insulin-preparations","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56218278","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EOnset%2C%20Peak%2C%20and%20Duration%20of%20Action%20of%20Human%20%3Cspan%20class%3D%27disableDrug%27%20tabindex%3D%270%27%20role%3D%27link%27%20onclick%3D%27javascript%3Avoid%280%29%3B%27%3EInsulin%3C%2Fspan%3E%20Preparations%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). Other premixed formulations include aspart <span class="genericDrug" data-showrollover="false">protamine</span> (a form of aspart modified to act like <span class="genericDrug" data-showrollover="false">insulin</span> isophane) with <span class="genericDrug" data-showrollover="false">insulin</span> aspart and a formulation of premixed degludec and aspart.</p></div><span id="v41829390" class="anchor"></span><div class="para"> <p>Different <span class="genericDrug" data-showrollover="false">insulin</span> types can be drawn into the same syringe for injection but should not be premixed in bottles except by a manufacturer. On occasion, mixing <span class="genericDrug" data-showrollover="false">insulins</span> may affect rates of <span class="genericDrug" data-showrollover="false">insulin</span> absorption, producing variability of effect and making glycemic control less predictable, especially if mixed <span class='symbol'>></span> 1 hour before use. <span class="genericDrug" data-showrollover="false">Insulin</span> glargine should never be mixed with any other <span class="genericDrug" data-showrollover="false">insulin</span>.</p></div><span id="v41829396" class="anchor"></span><div class="para"> <p>Many prefilled <span class="genericDrug" data-showrollover="false">insulin</span> pen devices are available as an alternative to the conventional vial and syringe method. <span class="genericDrug" data-showrollover="false">Insulin</span> pens may be more convenient for use away from home and may be preferable for patients with limited vision or manual dexterity. Spring-loaded self-injection devices (for use with a syringe) may be useful for the occasional patient who is fearful of injection, and syringe magnifiers are available for patients with low vision. "Smart" or "connected" <span class="genericDrug" data-showrollover="false">insulin</span> pens and pen caps communicate with a smart phone application to track administered <span class="genericDrug" data-showrollover="false">insulin</span> and make dosing recommendations. </p></div> </div> </section> <section id="v41829399" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v41829400" class="anchor"></span> <span class="genericDrug" data-showrollover="false">Insulin</span> pumps </h3> <div class="topic__content"> <span id="v41829401" class="anchor"></span><div class="para"> <p>Lispro or aspart can also be given continuously using an <span class="genericDrug" data-showrollover="false">insulin</span> pump (<a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84916152" data-toggle="tooltip" title="Insulin references" data-id="c1ea81b0-5673-4e65-9781-94e54d1d96bc" data-itemid="912a66b5-650e-4099-a978-4c78e044364d">1</a><span id="c1ea81b0-5673-4e65-9781-94e54d1d96bc" class="d-none xref"> <span class="tooltip-container"> <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84916152"> <span class="tooltip-content"> <span class="tooltip-heading"> <span class="genericDrug" data-showrollover="false">Insulin</span> references </span> General treatment of diabetes mellitus for all patients involves lifestyle changes, including diet and exercise. Appropriate monitoring and control of blood glucose levels is essential to prevent... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). In people with <span class="genericDrug" data-showrollover="false">insulin</span> resistance, higher concentration U500 is sometimes used. Continuous subcutaneous <span class="genericDrug" data-showrollover="false">insulin</span> infusion pumps can eliminate the need for multiple daily injections, provide maximal flexibility in the timing of meals, and substantially reduce variability in glucose levels. Disadvantages include cost, mechanical failures leading to interruptions in <span class="genericDrug" data-showrollover="false">insulin</span> supply, and the inconvenience of wearing an external device. Frequent and meticulous self-monitoring and close attention to pump function are necessary for safe and effective use of the <span class="genericDrug" data-showrollover="false">insulin</span> pump. </p></div><span id="v49788252" class="anchor"></span><div class="para"> <p>Sensor-augmented pump therapy is the use of <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html#v84915743" data-toggle="tooltip" title="Continuous glucose monitoring" data-id="82669354-f24a-4cd9-aa5b-e78041e4358b" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">continuous glucose monitoring</a><span id="82669354-f24a-4cd9-aa5b-e78041e4358b" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html#v84915743"> <span class="tooltip-content"> <span class="tooltip-heading"> Continuous glucose monitoring </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (CGM) in conjunction with an <span class="genericDrug" data-showrollover="false">insulin</span> pump. Several systems are available, in which glucose sensor data is communicated to an <span class="genericDrug" data-showrollover="false">insulin</span> pump and an algorithm adjusts <span class="genericDrug" data-showrollover="false">insulin</span> delivery through the pump. Systems with "low-glucose suspend" algorithms can stop <span class="genericDrug" data-showrollover="false">insulin</span> delivery when the sensor detects that glucose is low or is predicted to go low. </p></div><span id="v84916115" class="anchor"></span><div class="para"> <p>Hybrid closed-loop <span class="genericDrug" data-showrollover="false">insulin</span> delivery systems, or automated <span class="genericDrug" data-showrollover="false">insulin</span> delivery (AID) systems, are more sophisticated systems in which an algorithm calculates and adjusts the basal <span class="genericDrug" data-showrollover="false">insulin</span> dose based on CGM sensor input, which is then delivered by the connected <span class="genericDrug" data-showrollover="false">insulin</span> pump (<a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84916152" data-toggle="tooltip" title="Insulin references" data-id="6f829d29-94eb-4f34-9fd4-5aa9225df327" data-itemid="912a66b5-650e-4099-a978-4c78e044364d">2</a><span id="6f829d29-94eb-4f34-9fd4-5aa9225df327" class="d-none xref"> <span class="tooltip-container"> <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84916152"> <span class="tooltip-content"> <span class="tooltip-heading"> <span class="genericDrug" data-showrollover="false">Insulin</span> references </span> General treatment of diabetes mellitus for all patients involves lifestyle changes, including diet and exercise. Appropriate monitoring and control of blood glucose levels is essential to prevent... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v84916121" class="anchor"></span><div class="para"> <p>The available systems still require user input for mealtime bolus doses. There are several "fully closed-loop" systems being investigated, in which the pump automatically calculates both basal and bolus <span class="genericDrug" data-showrollover="false">insulin</span> doses with little to no input from the user. A new closed-loop system that uses meal announcements, rather than carbohydrate counting has been developed recently. </p></div> </div> </section> <section id="v29299717" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29299718" class="anchor"></span> Complications of <span class="genericDrug" data-showrollover="false">insulin</span> treatment </h3> <div class="topic__content"> <span id="v29299719" class="anchor"></span><div class="para"> <p>The <b>most common complication</b> is</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29299722" class="anchor"></span><div class="para"> <p> <a href="./{CA24AA75-752B-459D-87FB-FC53E81F4165}.html" data-toggle="tooltip" title="Hypoglycemia" data-id="4b5faedd-66bd-4caf-ae40-6887987313a3" data-itemid="ca24aa75-752b-459d-87fb-fc53e81f4165">Hypoglycemia</a><span id="4b5faedd-66bd-4caf-ae40-6887987313a3" class="d-none xref"> <span class="tooltip-container"> <a href="./{CA24AA75-752B-459D-87FB-FC53E81F4165}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypoglycemia </span> Hypoglycemia, or low plasma glucose level can result in sympathetic nervous system stimulation and central nervous system dysfunction. In patients with diabetes who take insulin or antihyperglycemic... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li></ul></div><span id="v29299724" class="anchor"></span><div class="para"> <p><b>Uncommon complications</b> include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29299727" class="anchor"></span><div class="para"> <p> <a href="./{A426E3E7-CFA3-48BC-8257-C6CFB7BC8C23}.html" data-toggle="tooltip" title="Hypokalemia" data-id="e953f176-61b0-4c2c-8b2b-e8387395d975" data-itemid="a426e3e7-cfa3-48bc-8257-c6cfb7bc8c23">Hypokalemia</a><span id="e953f176-61b0-4c2c-8b2b-e8387395d975" class="d-none xref"> <span class="tooltip-container"> <a href="./{A426E3E7-CFA3-48BC-8257-C6CFB7BC8C23}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypokalemia </span> Hypokalemia is serum potassium concentration < 3.5 mEq/L (< 3.5 mmol/L) caused by a deficit in total body potassium stores or abnormal movement of potassium into cells. The most common... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span></p></div></li><li class="topic__listitem"><span id="v29299730" class="anchor"></span><div class="para"> <p>Local allergic reactions</p></div></li><li class="topic__listitem"><span id="v29299732" class="anchor"></span><div class="para"> <p>Generalized allergic reaction</p></div></li><li class="topic__listitem"><span id="v29299734" class="anchor"></span><div class="para"> <p>Local fat atrophy or hypertrophy</p></div></li><li class="topic__listitem"><span id="v29299736" class="anchor"></span><div class="para"> <p>Circulating anti-<span class="genericDrug" data-showrollover="false">insulin</span> antibodies</p></div></li></ul></div><span id="v29299738" class="anchor"></span><div class="para"> <p><b>Hypoglycemia</b> is the most common complication of <span class="genericDrug" data-showrollover="false">insulin</span> treatment, occurring more often as patients try to achieve strict glucose control and approach near-normoglycemia or when blood glucose is not appropriately monitored. Symptoms of mild or moderate hypoglycemia include headache, diaphoresis, palpitations, light-headedness, blurred vision, agitation, and confusion. Symptoms of more severe hypoglycemia include seizures and loss of consciousness. In older patients, hypoglycemia may cause stroke-like symptoms of aphasia or hemiparesis and is more likely to precipitate stroke, myocardial infarction, and sudden death. </p></div><span id="v71803187" class="anchor"></span><div class="para"> <p>Patients should be taught to recognize symptoms of hypoglycemia. Patients with type 1 diabetes mellitus of long duration may be unaware of hypoglycemic episodes because they no longer experience autonomic symptoms (hypoglycemia unawareness). </p></div><span id="v71803188" class="anchor"></span><div class="para"> <p>In patients treated with <span class="genericDrug" data-showrollover="false">insulin</span> or glucose-lowering medications (eg, sulfonylureas), a blood glucose level <span class='symbol'>&lt</span> 70 mg/dL (<span class='symbol'>&lt</span> 3.9 mmol/L) is considered hypoglycemia and should be treated to avoid further decreases in glucose level and consequences of hypoglycemia. Symptoms of hypoglycemia usually respond rapidly to the ingestion of sugar. </p></div><span id="v71803190" class="anchor"></span><div class="para"> <p> <a href="./{CA24AA75-752B-459D-87FB-FC53E81F4165}.html#v989514" data-toggle="tooltip" title="Treatment" data-id="7126fade-8e1d-4b7d-9447-1fe1860fd4f1" data-itemid="ca24aa75-752b-459d-87fb-fc53e81f4165">Hypoglycemia is treated</a><span id="7126fade-8e1d-4b7d-9447-1fe1860fd4f1" class="d-none xref"> <span class="tooltip-container"> <a href="./{CA24AA75-752B-459D-87FB-FC53E81F4165}.html#v989514"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment </span> Hypoglycemia, or low plasma glucose level can result in sympathetic nervous system stimulation and central nervous system dysfunction. In patients with diabetes who take insulin or antihyperglycemic... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> with the administration of a form of sugar (oral glucose or sucrose or IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dextrose</span>) and/or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>glucagon</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dasiglucagon</span>. Patients at risk for hypoglycemia should have <span class="genericDrug" data-showrollover="false">glucagon</span> or <span class="genericDrug" data-showrollover="false">dasiglucagon</span> at home and elsewhere, and household members and trusted others should be instructed on management of hypoglycemic emergencies. </p></div><span id="v29299741" class="anchor"></span><div class="para"> <p><b>Hyperglycemia</b> may result from too high a bedtime <span class="genericDrug" data-showrollover="false">insulin</span> dose, which can drive glucose down and stimulate a counter-regulatory response, leading to morning hyperglycemia (Somogyi phenomenon). A more common cause of unexplained morning hyperglycemia, however, is a rise in early morning growth hormone (dawn phenomenon). In this case, the evening <span class="genericDrug" data-showrollover="false">insulin</span> dose should be increased, changed to a longer-acting preparation, or injected later.</p></div><span id="v29299747" class="anchor"></span><div class="para"> <p><b>Hypokalemia</b> may be caused by intracellular shifts of potassium due to <span class="genericDrug" data-showrollover="false">insulin</span>-induced stimulation of the sodium-potassium pump, but it is uncommon. <a href="./{A426E3E7-CFA3-48BC-8257-C6CFB7BC8C23}.html" data-toggle="tooltip" title="Hypokalemia" data-id="0fed32d5-d7e0-4698-9ead-2df6887a95b5" data-itemid="a426e3e7-cfa3-48bc-8257-c6cfb7bc8c23">Hypokalemia</a><span id="0fed32d5-d7e0-4698-9ead-2df6887a95b5" class="d-none xref"> <span class="tooltip-container"> <a href="./{A426E3E7-CFA3-48BC-8257-C6CFB7BC8C23}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypokalemia </span> Hypokalemia is serum potassium concentration < 3.5 mEq/L (< 3.5 mmol/L) caused by a deficit in total body potassium stores or abnormal movement of potassium into cells. The most common... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> more commonly occurs in acute care settings when body potassium stores may be depleted and IV <span class="genericDrug" data-showrollover="false">insulin</span> is used.</p></div><span id="v29299750" class="anchor"></span><div class="para"> <p><b>Local allergic reactions</b> at the site of <span class="genericDrug" data-showrollover="false">insulin</span> injections are rare, especially with the use of human <span class="genericDrug" data-showrollover="false">insulins</span>, but they may still occur in patients with latex allergy because of the natural rubber latex contained in vial stoppers. They can cause immediate pain or burning followed by erythema, pruritus, and induration—the latter sometimes persisting for days. Most reactions spontaneously disappear after weeks of continued injection and require no specific treatment, although antihistamines may provide symptomatic relief.</p></div><span id="v29299753" class="anchor"></span><div class="para"> <p><b>Generalized allergic reaction</b> is extremely rare with human <span class="genericDrug" data-showrollover="false">insulins</span> but can occur when <span class="genericDrug" data-showrollover="false">insulin</span> is restarted after a lapse in treatment. Symptoms develop 30 minutes to 2 hours after injection and include urticaria, angioedema, pruritus, bronchospasm, and anaphylaxis. Treatment with antihistamines often suffices, but <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>epinephrine</span> and IV glucocorticoids may be needed. If <span class="genericDrug" data-showrollover="false">insulin</span> treatment is needed after a generalized allergic reaction, skin testing with a panel of purified <span class="genericDrug" data-showrollover="false">insulin</span> preparations and desensitization should be done.</p></div><span id="v29299758" class="anchor"></span><div class="para"> <p><b>Local fat hypertrophy,</b> or lipohypertrophy, is a common reaction caused by the lipogenic effect of <span class="genericDrug" data-showrollover="false">insulin</span>. Lipohypertrophy can lead to variability of <span class="genericDrug" data-showrollover="false">insulin</span> absorption and can be avoided by rotating injection sites. </p></div><span id="v84916126" class="anchor"></span><div class="para"> <p><b>Lipoatrophy,</b> a loss of subcutaneous adipose tissue, is thought to result from an immune reaction to a component of <span class="genericDrug" data-showrollover="false">insulin</span> preparation. It has become very rare with the use of human <span class="genericDrug" data-showrollover="false">insulins</span> and can be treated with corticosteroids. </p></div><span id="v29299760" class="anchor"></span><div class="para"> <p><b>Circulating anti-<span class="genericDrug" data-showrollover="false">insulin</span> antibodies</b> are a very rare cause of <span class="genericDrug" data-showrollover="false">insulin</span> resistance in patients taking animal <span class="genericDrug" data-showrollover="false">insulin</span> and sometimes in those taking human and analog <span class="genericDrug" data-showrollover="false">insulins</span>. <span class="genericDrug" data-showrollover="false">Insulin</span> resistance due to circulating anti-<span class="genericDrug" data-showrollover="false">insulin</span> antibodies can sometimes be treated by changing <span class="genericDrug" data-showrollover="false">insulin</span> preparations (eg, from animal to human <span class="genericDrug" data-showrollover="false">insulin</span>) and by administering corticosteroids or immunosuppressants and sometimes plasmapheresis if necessary.</p></div> </div> </section> <section id="v29299766" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29299767" class="anchor"></span> <span class="genericDrug" data-showrollover="false">Insulin</span> regimens for type 1 diabetes </h3> <div class="topic__content"> <span id="v29299769" class="anchor"></span><div class="para"> <p>Regimens range from twice a day split-mixed (eg, split doses of rapid- and intermediate-acting <span class="genericDrug" data-showrollover="false">insulins</span>) to more physiologic basal-bolus regimens using multiple daily injections (eg, single fixed [basal] dose of long-acting and variable prandial [bolus] doses of rapid-acting <span class="genericDrug" data-showrollover="false">insulin</span>) or an <span class="genericDrug" data-showrollover="false">insulin</span> pump. </p></div><span id="v84916134" class="anchor"></span><div class="para"> <p>Intensive treatment, defined as glucose monitoring <span class='symbol'>≥</span> 4 times a day and <span class='symbol'>≥</span> 3 injections a day or continuous <span class="genericDrug" data-showrollover="false">insulin</span> infusion, is more effective than conventional treatment (1 to 2 <span class="genericDrug" data-showrollover="false">insulin</span> injections a day with or without monitoring) for preventing <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html#v29299324" data-toggle="tooltip" title="Diabetic Retinopathy" data-id="de05d2e8-1e38-4f0a-9eca-84bc1cdb221b" data-itemid="ec552a1a-fa57-4ab9-a8da-ce820d465c83">diabetic retinopathy</a><span id="de05d2e8-1e38-4f0a-9eca-84bc1cdb221b" class="d-none xref"> <span class="tooltip-container"> <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html#v29299324"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetic Retinopathy </span> In patients with diabetes mellitus, years of poorly controlled hyperglycemia lead to multiple, primarily vascular, complications that affect small vessels (microvascular), large vessels (macrovascular)... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/9/6/496-cellulitis-with-foot-ulcer-slide-98a-springer-crop-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diabetic Retinopathy" loading="lazy"> </span> </a> </span> </span>, <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html#v29299332" data-toggle="tooltip" title="Diabetic Nephropathy" data-id="ff86ba9f-d691-46f7-9000-57ca17568b17" data-itemid="ec552a1a-fa57-4ab9-a8da-ce820d465c83">nephropathy</a><span id="ff86ba9f-d691-46f7-9000-57ca17568b17" class="d-none xref"> <span class="tooltip-container"> <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html#v29299332"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetic Nephropathy </span> In patients with diabetes mellitus, years of poorly controlled hyperglycemia lead to multiple, primarily vascular, complications that affect small vessels (microvascular), large vessels (macrovascular)... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/9/6/496-cellulitis-with-foot-ulcer-slide-98a-springer-crop-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diabetic Nephropathy" loading="lazy"> </span> </a> </span> </span>, and <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html#v29299343" data-toggle="tooltip" title="Diabetic Neuropathy" data-id="aa0f92f1-e6ca-49aa-9728-1b249b6d4fb0" data-itemid="ec552a1a-fa57-4ab9-a8da-ce820d465c83">neuropathy</a><span id="aa0f92f1-e6ca-49aa-9728-1b249b6d4fb0" class="d-none xref"> <span class="tooltip-container"> <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html#v29299343"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetic Neuropathy </span> In patients with diabetes mellitus, years of poorly controlled hyperglycemia lead to multiple, primarily vascular, complications that affect small vessels (microvascular), large vessels (macrovascular)... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/9/6/496-cellulitis-with-foot-ulcer-slide-98a-springer-crop-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diabetic Neuropathy" loading="lazy"> </span> </a> </span> </span>. However, intensive therapy may result in more frequent episodes of hypoglycemia and weight gain and is more effective in patients who are able and willing to take an active role in their self-care.</p></div><span id="v29299775" class="anchor"></span><div class="para"> <p>In general, most patients with type 1 diabetes mellitus can start with a total dose of 0.2 to 0.8 units of <span class="genericDrug" data-showrollover="false">insulin</span>/kg/day. Patients with obesity may require higher doses. Physiologic replacement involves giving 40 to 60% of the daily <span class="genericDrug" data-showrollover="false">insulin</span> dose as an intermediate- or long-acting preparation to cover basal needs, with the remainder given as a rapid- or short-acting preparation to cover postprandial increases. This approach is most effective when the dose of rapid- or short-acting <span class="genericDrug" data-showrollover="false">insulin</span> is adjusted for preprandial blood glucose level and anticipated meal content. </p></div><span id="v84916140" class="anchor"></span><div class="para"> <p>A correction factor, also known as the <span class="genericDrug" data-showrollover="false">insulin</span> sensitivity factor, is the amount that 1 unit of <span class="genericDrug" data-showrollover="false">insulin</span> will lower a patient's blood glucose level over 2 to 4 hours; this factor is often calculated using the "1800 rule" when rapid-acting <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>insulin</span> is used for correction (1800/total daily dose of <span class="genericDrug" data-showrollover="false">insulin</span>). For regular <span class="genericDrug" data-showrollover="false">insulin</span>, a "1500 rule" can be used. A correction dose (current glucose level - target glucose level/ correction factor) is the dose of <span class="genericDrug" data-showrollover="false">insulin</span> that will lower the blood glucose level into the target range. This correction dose can be added to the prandial <span class="genericDrug" data-showrollover="false">insulin</span> dose that is calculated for the number of carbohydrates in a meal, using the carbohydrate-to-<span class="genericDrug" data-showrollover="false">insulin</span> ratio (CIR). The CIR is often calculated using the "500 rule" (500/total daily dose).</p></div><span id="v29299786" class="anchor"></span><div class="para"> <p>To illustrate calculation of a lunchtime dose, assume the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29299789" class="anchor"></span><div class="para"> <p>Preprandial fingerstick glucose: 240 mg/dL (13.3 mmol/L)</p></div></li><li class="topic__listitem"><span id="v29299791" class="anchor"></span><div class="para"> <p>Total daily dose of <span class="genericDrug" data-showrollover="false">insulin</span>: 30 units basal <span class="genericDrug" data-showrollover="false">insulin</span><span class='symbol'>+</span> 10 units bolus <span class="genericDrug" data-showrollover="false">insulin</span> per meal <span class='symbol'>=</span> 60 units total, daily</p></div></li><li class="topic__listitem"><span id="v29299793" class="anchor"></span><div class="para"> <p>Correction factor (<span class="genericDrug" data-showrollover="false">insulin</span> sensitivity factor): 1800/60 <span class='symbol'>=</span> 30 mg/dL/unit (1.7 mEq/L/unit, or 1.7 mmol/L)</p></div></li><li class="topic__listitem"><span id="v29299796" class="anchor"></span><div class="para"> <p>Estimated carbohydrate content of upcoming meal: 50 g </p></div></li><li class="topic__listitem"><span id="v29299798" class="anchor"></span><div class="para"> <p>Carbohydrate:<span class="genericDrug" data-showrollover="false">insulin</span> ratio (CIR): 500/60 <span class='symbol'>=</span> 8:1 </p></div></li><li class="topic__listitem"><span id="v29299801" class="anchor"></span><div class="para"> <p>Target glucose: 120 mg/dL (6.7 mmol/L)</p></div></li></ul></div><span id="v29299802" class="anchor"></span><div class="para"> <p>Prandial <span class="genericDrug" data-showrollover="false">insulin</span> dose <span class='symbol'>=</span> 50 g carbohydrate divided by 8 g/unit <span class="genericDrug" data-showrollover="false">insulin</span><span class='symbol'> =</span> 6 units</p></div><span id="v29299804" class="anchor"></span><div class="para"> <p>Correction dose <span class='symbol'>=</span> (240 mg/dL <span class='symbol'>-</span> 120 mg/dL)/30 correction factor <span class='symbol'>=</span> 4 units ([13.3 mmol/L <span class='symbol'>-</span> 6.7 mmol/L]/1.7 <span class='symbol'>=</span> 4) </p></div><span id="v29299805" class="anchor"></span><div class="para"> <p>Total dose prior to this meal <span class='symbol'>=</span> prandial dose <span class='symbol'>+</span> correction dose <span class='symbol'>=</span> 6 <span class='symbol'>+</span> 4 <span class='symbol'>=</span> 10 units rapid-acting <span class="genericDrug" data-showrollover="false">insulin</span></p></div><span id="v29299807" class="anchor"></span><div class="para"> <p>Such physiologic regimens allow greater freedom of lifestyle because patients can skip or time-shift meals and maintain normoglycemia. These recommendations are for initiation of therapy; thereafter, choice of regimens generally rests on physiologic response and patient and physician preferences. The carbohydrate-to-<span class="genericDrug" data-showrollover="false">insulin</span> ratio (CIR) and sensitivity factors need to be fine-tuned and changed according to how the patient responds to <span class="genericDrug" data-showrollover="false">insulin</span> doses. This adjustment requires working closely with a diabetes specialist. </p></div> </div> </section> <section id="v29299810" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29299811" class="anchor"></span> <span class="genericDrug" data-showrollover="false">Insulin</span> regimens for type 2 diabetes </h3> <div class="topic__content"> <span id="v29299813" class="anchor"></span><div class="para"> <p>Regimens for type 2 diabetes mellitus also vary. In many patients, glucose levels are adequately controlled with lifestyle changes and non-<span class="genericDrug" data-showrollover="false">insulin</span> antihyperglycemic medications, but <span class="genericDrug" data-showrollover="false">insulin</span> should be added when glucose remains inadequately controlled by <span class='symbol'>≥</span> 3 medications, if the patient is suspected of having <span class="genericDrug" data-showrollover="false">insulin</span> deficiency, or the blood sugar level is very high. Although uncommon, adult-onset type 1 diabetes may be the cause. In most cases, in women who become pregnant, <span class="genericDrug" data-showrollover="false">insulin</span> should replace non-<span class="genericDrug" data-showrollover="false">insulin</span> antihyperglycemic medications. </p></div><span id="v49788266" class="anchor"></span><div class="para"> <p>The rationale for combination therapy is strongest for use of <span class="genericDrug" data-showrollover="false">insulin</span> with oral biguanides and <span class="genericDrug" data-showrollover="false">insulin</span> sensitizers. Regimens vary from a single daily injection of long- or intermediate-acting <span class="genericDrug" data-showrollover="false">insulin</span> (usually at bedtime) to the multiple-injection regimen used by patients with type 1 diabetes. In general, the simplest effective regimen is preferred. Because of <span class="genericDrug" data-showrollover="false">insulin</span> resistance, some patients with type 2 diabetes require very large doses (<span class='symbol'>></span> 2 units/kg/day). A common complication is weight gain, which is mostly attributable to reduction in loss of glucose in urine and improved metabolic efficiency.</p></div> </div> </section> <section id="v84916151" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v84916152" class="anchor"></span> <span class="genericDrug" data-showrollover="false">Insulin</span> references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84916156" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31980120/">Kravarusic J, Aleppo G</a>: Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes. <i>Endocrinol Metab Clin North Am</i> 49(1):37–55, 2020. doi: 10.1016/j.ecl.2019.10.006</p></div></li><li class="topic__listitem"><span id="v84916159" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/35994106/">Renard E</a>. Automated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>insulin</span> delivery systems: from early research to routine care of type 1 diabetes. <i>Acta Diabetol</i> 2023;60(2):151-161. doi:10.1007/s00592-022-01929-5</p></div></li><li class="topic__listitem"><span id="v84916162" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34116789/">Grunberger G, Sherr J, Allende M, et al</a>. American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus. <i>Endocr Pract</i> 2021;27(6):505-537. doi:10.1016/j.eprac.2021.04.008</p></div></li></ul></div> </div> </section> </div> </section> <section id="v29299822" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v29299823" class="anchor"></span> Oral Antihyperglycemic Medications </h2> <div class="topic__content"> <span id="v29299826" class="anchor"></span><div class="para"> <p>Oral antihyperglycemic medications (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"bf86f264-6945-487c-87d4-c425b6d5b7ff","Title":"Characteristics%20of%20Oral%20Antihyperglycemics","ShareUrlTitle":"characteristics-of-oral-antihyperglycemics","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v84915273","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ECharacteristics%20of%20Oral%20Antihyperglycemics%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>) are a mainstay of treatment for type 2 diabetes mellitus, along with injectable <span class="genericDrug" data-showrollover="false">glucagon</span>-like peptide-1 (GLP-1) receptor agonists. Oral antihyperglycemic medications may </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29299832" class="anchor"></span><div class="para"> <p>Enhance pancreatic <span class="genericDrug" data-showrollover="false">insulin</span> secretion (secretagogues) </p></div></li><li class="topic__listitem"><span id="v29299835" class="anchor"></span><div class="para"> <p>Sensitize peripheral tissues to <span class="genericDrug" data-showrollover="false">insulin</span> (sensitizers) </p></div></li><li class="topic__listitem"><span id="v29299838" class="anchor"></span><div class="para"> <p>Impair gastrointestinal absorption of glucose </p></div></li><li class="topic__listitem"><span id="v29299840" class="anchor"></span><div class="para"> <p>Increase glycosuria</p></div></li></ul></div><span id="v29299841" class="anchor"></span><div class="para"> <p>Medications with different mechanisms of action may be synergistic.</p></div> <span id="v84915272"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v84915274"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"bf86f264-6945-487c-87d4-c425b6d5b7ff","Title":"Characteristics%20of%20Oral%20Antihyperglycemics","ShareUrlTitle":"characteristics-of-oral-antihyperglycemics","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v84915273","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Characteristics%20of%20Oral%20Antihyperglycemics","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="bf86f264-6945-487c-87d4-c425b6d5b7ff"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'bf86f264-6945-487c-87d4-c425b6d5b7ff' }, async: true, success: function (data) { $('#bf86f264-6945-487c-87d4-c425b6d5b7ff').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v49788320" class="anchor"></span><div class="para"> <p>(See below for information on <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v29300316" data-toggle="tooltip" title="Glucagon-like peptide-1 (GLP-1) receptor agonists" data-id="3f913709-e266-47c2-b056-4e82a30a6b63" data-itemid="912a66b5-650e-4099-a978-4c78e044364d"><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Glucagon</span>-like peptide-1 (GLP1) receptor agonists</a><span id="3f913709-e266-47c2-b056-4e82a30a6b63" class="d-none xref"> <span class="tooltip-container"> <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v29300316"> <span class="tooltip-content"> <span class="tooltip-heading"> <span class="genericDrug" data-showrollover="false">Glucagon</span>-like peptide-1 (GLP-1) receptor agonists </span> General treatment of diabetes mellitus for all patients involves lifestyle changes, including diet and exercise. Appropriate monitoring and control of blood glucose levels is essential to prevent... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>.)</p></div> <section id="v29300262" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29300263" class="anchor"></span> Sulfonylureas </h3> <div class="topic__content"> <span id="v29300264" class="anchor"></span><div class="para"> <p>Sulfonylureas (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>glyburide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>glipizide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>glimepiride</span>) are <span class="genericDrug" data-showrollover="false">insulin</span> secretagogues. They lower plasma glucose by stimulating pancreatic beta-cell <span class="genericDrug" data-showrollover="false">insulin</span> secretion and may secondarily improve peripheral and hepatic <span class="genericDrug" data-showrollover="false">insulin</span> sensitivity by reducing glucose toxicity. First-generation sulfonylureas (acetohexamide, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chlorpropamide</span>, tolazamide, tolbutamide) are more likely to cause adverse effects and are used infrequently. All sulfonylureas promote hyperinsulinemia and weight gain of 2 to 5 kg, which over time may potentiate <span class="genericDrug" data-showrollover="false">insulin</span> resistance and limit their usefulness. All also can cause <a href="./{CA24AA75-752B-459D-87FB-FC53E81F4165}.html" data-toggle="tooltip" title="Hypoglycemia" data-id="defadd7f-f091-472b-b282-b416db1e2884" data-itemid="ca24aa75-752b-459d-87fb-fc53e81f4165">hypoglycemia</a><span id="defadd7f-f091-472b-b282-b416db1e2884" class="d-none xref"> <span class="tooltip-container"> <a href="./{CA24AA75-752B-459D-87FB-FC53E81F4165}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hypoglycemia </span> Hypoglycemia, or low plasma glucose level can result in sympathetic nervous system stimulation and central nervous system dysfunction. In patients with diabetes who take insulin or antihyperglycemic... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Risk factors include age <span class='symbol'>></span> 65 years, use of long-acting medications (especially <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chlorpropamide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>glyburide</span>, or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>glipizide</span>), erratic eating and exercise, and renal or hepatic insufficiency. </p></div><span id="v29300271" class="anchor"></span><div class="para"> <p>Hypoglycemia caused by long-acting medications may last for days after treatment cessation, occasionally causes permanent neurologic disability, and can be fatal. For these reasons, some physicians hospitalize hypoglycemic patients, especially older ones. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chlorpropamide</span> also causes the <a href="./{1E596F9E-1A6E-452B-AAB8-71E64386EE64}.html" data-toggle="tooltip" title="Syndrome of Inappropriate ADH Secretion (SIADH)" data-id="29235c06-9df5-48cc-9b3a-da9b7fdd09b0" data-itemid="1e596f9e-1a6e-452b-aab8-71e64386ee64">syndrome of inappropriate ADH secretion</a><span id="29235c06-9df5-48cc-9b3a-da9b7fdd09b0" class="d-none xref"> <span class="tooltip-container"> <a href="./{1E596F9E-1A6E-452B-AAB8-71E64386EE64}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Syndrome of Inappropriate ADH Secretion (SIADH) </span> The syndrome of inappropriate ADH (vasopressin) secretion is defined as less than maximally dilute urine in the presence of serum hypo-osmolality, in patients with normal adrenal, thyroid, renal... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Most patients taking sulfonylureas alone eventually require additional medications to achieve normoglycemia, suggesting that sulfonylureas may exhaust beta-cell function. However, worsening of <span class="genericDrug" data-showrollover="false">insulin</span> secretion and <span class="genericDrug" data-showrollover="false">insulin</span> resistance is probably more a feature of diabetes mellitus itself than of medications used to treat it.</p></div> </div> </section> <section id="v29300275" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29300276" class="anchor"></span> Short-acting <span class="genericDrug" data-showrollover="false">insulin</span> secretagogues </h3> <div class="topic__content"> <span id="v29300277" class="anchor"></span><div class="para"> <p>Short-acting <span class="genericDrug" data-showrollover="false">insulin</span> secretagogues (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>repaglinide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nateglinide</span>) stimulate <span class="genericDrug" data-showrollover="false">insulin</span> secretion in a manner similar to sulfonylureas. They are faster acting, however, and may stimulate <span class="genericDrug" data-showrollover="false">insulin</span> secretion more during meals than at other times. Thus, they may be especially effective for reducing postprandial hyperglycemia and appear to have lower risk of hypoglycemia. There may be some weight gain, although apparently less than with sulfonylureas. Patients who have not responded to other oral medications (eg, sulfonylureas, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>metformin</span>) are not likely to respond to these medications.</p></div> </div> </section> <section id="v29300281" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29300282" class="anchor"></span> Biguanides </h3> <div class="topic__content"> <span id="v29300283" class="anchor"></span><div class="para"> <p>Biguanides (<span class="genericDrug" data-showrollover="false">metformin</span>) lower plasma glucose by decreasing hepatic glucose production (gluconeogenesis and glycogenolysis). They are considered peripheral <span class="genericDrug" data-showrollover="false">insulin</span> sensitizers, but their stimulation of peripheral glucose uptake may simply be a result of reductions in glucose due to their hepatic effects. Biguanides also lower lipid levels and may also decrease gastrointestinal nutrient absorption and increase beta-cell sensitivity to circulating glucose. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Metformin</span> is the only biguanide commercially available in the United States. It is at least as effective as sulfonylureas in reducing plasma glucose, rarely causes hypoglycemia, and can be safely used with other medications and <span class="genericDrug" data-showrollover="false">insulin</span>. In addition, <span class="genericDrug" data-showrollover="false">metformin</span> does not cause weight gain and may even promote weight loss by suppressing appetite. However, the medication commonly causes gastrointestinal adverse effects (eg, dyspepsia, diarrhea), which for most people recede with time. Less commonly, <span class="genericDrug" data-showrollover="false">metformin</span> causes <span class="genericDrug" data-showrollover="false">vitamin B12</span> malabsorption, but clinically significant anemia is rare. </p></div><span id="v29300286" class="anchor"></span><div class="para"> <p>Contribution of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>metformin</span> to life-threatening <a href="./{D14FD7DA-5C9F-4CC9-B0CC-F79C4E61D23E}.html" data-toggle="tooltip" title="Lactic Acidosis" data-id="2ca717ee-54b5-4d6b-954b-47a84b78bd66" data-itemid="d14fd7da-5c9f-4cc9-b0cc-f79c4e61d23e">lactic acidosis</a><span id="2ca717ee-54b5-4d6b-954b-47a84b78bd66" class="d-none xref"> <span class="tooltip-container"> <a href="./{D14FD7DA-5C9F-4CC9-B0CC-F79C4E61D23E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Lactic Acidosis </span> Lactic acidosis is a high anion gap metabolic acidosis due to elevated blood lactate. Lactic acidosis results from overproduction of lactate, decreased metabolism of lactate, or both. (See also... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> is very rare, but the medication is contraindicated in patients at risk of acidemia (including those with significant renal insufficiency, hypoxia or severe respiratory disease, alcohol use disorder, other forms of metabolic acidosis, or dehydration). The medication should be withheld during surgery, administration of IV contrast, and any serious illness. Many people receiving <span class="genericDrug" data-showrollover="false">metformin</span> monotherapy eventually require an additional medication.</p></div> </div> </section> <section id="v29300287" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29300288" class="anchor"></span> Thiazolidinediones </h3> <div class="topic__content"> <span id="v29300289" class="anchor"></span><div class="para"> <p>Thiazolidinediones (TZDs—<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pioglitazone</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rosiglitazone</span>) decrease peripheral <span class="genericDrug" data-showrollover="false">insulin</span> resistance (<span class="genericDrug" data-showrollover="false">insulin</span> sensitizers). The medications bind a nuclear receptor primarily present in fat cells (peroxisome-proliferator-activated receptor-gamma [PPAR-<span class='symbol'>γ</span>]) that is involved in the transcription of genes that regulate glucose and lipid metabolism. TZDs also increase high-density lipoprotein (HDL) levels, lower triglycerides, and may have anti-inflammatory and anti-atherosclerotic effects. TZDs are as effective as sulfonylureas and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>metformin</span> in reducing hemoglobin A1C. TZDs may be beneficial in treatment of <a href="./{F358670D-7146-462A-BFE2-A4B3B3D2DA0B}.html" data-toggle="tooltip" title="Metabolic Dysfunction–Associated Liver Disease (MASLD)" data-id="6d8a83e0-03dd-4cb9-ad5c-ea15a88846f8" data-itemid="f358670d-7146-462a-bfe2-a4b3b3d2da0b">metabolic associated steatotic liver disease</a><span id="6d8a83e0-03dd-4cb9-ad5c-ea15a88846f8" class="d-none xref"> <span class="tooltip-container"> <a href="./{F358670D-7146-462A-BFE2-A4B3B3D2DA0B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Metabolic Dysfunction–Associated Liver Disease (MASLD) </span> Steatotic liver disease is due to excessive accumulation of lipid in hepatocytes. Metabolic dysfunction–associated liver disease (MASLD) includes simple fatty infiltration (a benign condition... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (MASLD; formerly nonalcoholic fatty liver disease [NAFLD]).</p></div><span id="v29300293" class="anchor"></span><div class="para"> <p>Though one TZD (troglitazone) caused acute liver failure, currently available medications have not proven hepatotoxic. Nevertheless, periodic monitoring of liver function is recommended. TZDs may cause peripheral edema, especially in patients taking <span class="genericDrug" data-showrollover="false">insulin</span>, and may worsen <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html" data-toggle="tooltip" title="Heart Failure (HF)" data-id="a7861a71-d66f-498c-96c1-e3c274f8e312" data-itemid="b4986cfa-b2a7-45d5-b89b-470df0ead991">heart failure</a><span id="a7861a71-d66f-498c-96c1-e3c274f8e312" class="d-none xref"> <span class="tooltip-container"> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Heart Failure (HF) </span> Heart failure (HF) is a syndrome of ventricular dysfunction. Left ventricular (LV) failure causes shortness of breath and fatigue, and right ventricular (RV) failure causes peripheral and abdominal... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/3/2/a/32a-and-32b-chest-xray-patient-bilateral-pleural-effusions.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Heart Failure (HF)" loading="lazy"> </span> </a> </span> </span> in susceptible patients. Weight gain, due to fluid retention and increased adipose tissue mass, is common and may be substantial (<span class='symbol'>></span> 10 kg) in some patients. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rosiglitazone</span> may increase risk of <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html" data-toggle="tooltip" title="Heart Failure (HF)" data-id="bd59ca1c-9047-4764-9bf9-75d4bccb7955" data-itemid="b4986cfa-b2a7-45d5-b89b-470df0ead991">heart failure</a><span id="bd59ca1c-9047-4764-9bf9-75d4bccb7955" class="d-none xref"> <span class="tooltip-container"> <a href="./{B4986CFA-B2A7-45D5-B89B-470DF0EAD991}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Heart Failure (HF) </span> Heart failure (HF) is a syndrome of ventricular dysfunction. Left ventricular (LV) failure causes shortness of breath and fatigue, and right ventricular (RV) failure causes peripheral and abdominal... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/3/2/a/32a-and-32b-chest-xray-patient-bilateral-pleural-effusions.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Heart Failure (HF)" loading="lazy"> </span> </a> </span> </span>, <a href="./{EAD663A1-8F93-4B72-881E-2BCEFEC7B069}.html" data-toggle="tooltip" title="Angina Pectoris" data-id="363d5098-df0e-42e7-81ec-ac672d647e76" data-itemid="ead663a1-8f93-4b72-881e-2bcefec7b069">angina</a><span id="363d5098-df0e-42e7-81ec-ac672d647e76" class="d-none xref"> <span class="tooltip-container"> <a href="./{EAD663A1-8F93-4B72-881E-2BCEFEC7B069}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Angina Pectoris </span> Angina pectoris is a clinical syndrome of precordial discomfort or pressure due to transient myocardial ischemia without infarction. It is typically precipitated by exertion or psychologic stress... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html" data-toggle="tooltip" title="Acute Myocardial Infarction (MI)" data-id="301e210c-950d-4e93-98d0-e0945fa7c3d1" data-itemid="1fe201c9-088a-4951-838b-b2c8bb45a77e">myocardial infarction</a><span id="301e210c-950d-4e93-98d0-e0945fa7c3d1" class="d-none xref"> <span class="tooltip-container"> <a href="./{1FE201C9-088A-4951-838B-B2C8BB45A77E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Myocardial Infarction (MI) </span> Acute myocardial infarction is myocardial necrosis resulting from acute obstruction of a coronary artery. Symptoms include chest discomfort with or without dyspnea, nausea, and/or diaphoresis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/0/0/600-nstemi-s192-springer-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Myocardial Infarction (MI)" loading="lazy"> </span> </a> </span> </span>, <a href="./{E61C2983-3440-4F96-AA2E-B108231A4E5D}.html" data-toggle="tooltip" title="Overview of Stroke" data-id="059a2297-af71-4862-ac4b-c9678676ba75" data-itemid="e61c2983-3440-4f96-aa2e-b108231a4e5d">stroke</a><span id="059a2297-af71-4862-ac4b-c9678676ba75" class="d-none xref"> <span class="tooltip-container"> <a href="./{E61C2983-3440-4F96-AA2E-B108231A4E5D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Stroke </span> Strokes are a heterogeneous group of disorders involving sudden, focal interruption of cerebral blood flow that causes neurologic deficit. Strokes can be Ischemic (80%), typically resulting... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/u/b/subacute-mca-infarct-ctisus-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Stroke" loading="lazy"> </span> </a> </span> </span>, and fracture. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pioglitazone</span> may increase the risk of <a href="./{1B51D834-5418-4525-AC63-8AD5409C5E10}.html" data-toggle="tooltip" title="Bladder Cancer" data-id="8e920629-aa30-4a68-b434-218d05938e2c" data-itemid="1b51d834-5418-4525-ac63-8ad5409c5e10">bladder cancer</a><span id="8e920629-aa30-4a68-b434-218d05938e2c" class="d-none xref"> <span class="tooltip-container"> <a href="./{1B51D834-5418-4525-AC63-8AD5409C5E10}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Bladder Cancer </span> Bladder cancer is usually transitional cell (urothelial) carcinoma. Patients usually present with hematuria (most commonly) or irritative voiding symptoms such as frequency and/or urgency; later... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/1/c0105027-cystoscopy-bladder-cancer-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Bladder Cancer" loading="lazy"> </span> </a> </span> </span> (although data are conflicting), heart failure, and fractures.</p></div> </div> </section> <section id="v29300295" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29300296" class="anchor"></span> Alpha-glucosidase inhibitors </h3> <div class="topic__content"> <span id="v29300297" class="anchor"></span><div class="para"> <p>Alpha-glucosidase inhibitors (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>acarbose</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>miglitol</span>) competitively inhibit intestinal enzymes that hydrolyze dietary carbohydrates; carbohydrates are digested and absorbed more slowly, thereby lowering postprandial plasma glucose. Alpha-glucosidase inhibitors are less effective than other oral medications in reducing plasma glucose, and patients often stop the medications because they may cause dyspepsia, flatulence, and diarrhea. But the medications are otherwise safe and can be used in combination with all other oral antihyperglycemic medications and with <span class="genericDrug" data-showrollover="false">insulin</span>.</p></div> </div> </section> <section id="v29300299" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29300300" class="anchor"></span> Dipeptidyl peptidase-4 inhibitors </h3> <div class="topic__content"> <span id="v29300301" class="anchor"></span><div class="para"> <p>Dipeptidyl peptidase-4 inhibitors (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>alogliptin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>linagliptin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>saxagliptin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>sitagliptin</span>) prolong the action of endogenous <span class="genericDrug" data-showrollover="false">glucagon</span>-like peptide-1 (GLP-1) by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which is involved in the breakdown of GLP-1. GLP-1 is a peptide made in the small intestine that stimulates <span class="genericDrug" data-showrollover="false">insulin</span> secretion and inhibits <span class="genericDrug" data-showrollover="false">glucagon</span> secretion; prolonging its action thereby lowers plasma glucose. There is a slight increase in risk for <a href="./{133C73BA-6613-4F84-BFB4-DC4A1367BB58}.html" data-toggle="tooltip" title="Overview of Pancreatitis" data-id="7e50be80-5e96-45d3-b5ed-0d720696f51d" data-itemid="133c73ba-6613-4f84-bfb4-dc4a1367bb58">pancreatitis</a><span id="7e50be80-5e96-45d3-b5ed-0d720696f51d" class="d-none xref"> <span class="tooltip-container"> <a href="./{133C73BA-6613-4F84-BFB4-DC4A1367BB58}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Pancreatitis </span> Pancreatitis is classified as either acute or chronic. Acute pancreatitis is inflammation that resolves both clinically and histologically. Chronic pancreatitis is characterized by histologic... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> with DPP-4 inhibitors, but they are otherwise considered safe and well-tolerated. The hemoglobin A1C decrease is modest with DPP-4 inhibitors. </p></div> </div> </section> <section id="v29300302" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29300303" class="anchor"></span> Sodium-glucose co-transporter 2 inhibitors </h3> <div class="topic__content"> <span id="v29300304" class="anchor"></span><div class="para"> <p>Sodium-glucose co-transporter 2 (SGLT2) inhibitors (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bexagliflozin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>canagliflozin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dapagliflozin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>empagliflozin</span>, ertugiflozin) inhibit SGLT2 in the proximal tubule of the kidney, which blocks glucose reabsorption, thus causing glycosuria and lowering plasma glucose. SGLT2 inhibitors may also cause modest weight loss and lowering of blood pressure. SGLT-2 inhibitors decrease mortality, major adverse cardiovascular events, and heart failure hospitalizations in patients with an increased risk for cardiovascular disease. In addition SGLT-2 inhibitors prevent progression of <a href="./{291C26B0-7C10-48A8-8057-7D2D9EE60EE6}.html" data-toggle="tooltip" title="Chronic Kidney Disease" data-id="f071393f-32c8-450c-8564-be9af0a7a5d3" data-itemid="291c26b0-7c10-48a8-8057-7d2d9ee60ee6">chronic kidney disease</a><span id="f071393f-32c8-450c-8564-be9af0a7a5d3" class="d-none xref"> <span class="tooltip-container"> <a href="./{291C26B0-7C10-48A8-8057-7D2D9EE60EE6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Chronic Kidney Disease </span> Chronic kidney disease (CKD) is long-standing, progressive deterioration of renal function. Symptoms develop slowly and in advanced stages include anorexia, nausea, vomiting, stomatitis, dysgeusia... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/3/3/633-uremic-frost-springer-high-with-arrow-cropped.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Chronic Kidney Disease" loading="lazy"> </span> </a> </span> </span> in patients with diabetes and reduced glomerular filtration rate or albuminuria. </p></div><span id="v29300305" class="anchor"></span><div class="para"> <p>The most common adverse effects are genitourinary infections, especially mycotic infections. Orthostatic symptoms can also occur. SGLT-2 inhibitors can cause <a href="./{F81143FB-A7CE-4C85-913C-222DEE4C7358}.html" data-toggle="tooltip" title="Diabetic Ketoacidosis (DKA)" data-id="18dc4a7a-e7e9-434e-b4a3-ab589e61cdfe" data-itemid="f81143fb-a7ce-4c85-913c-222dee4c7358">diabetic ketoacidosis</a><span id="18dc4a7a-e7e9-434e-b4a3-ab589e61cdfe" class="d-none xref"> <span class="tooltip-container"> <a href="./{F81143FB-A7CE-4C85-913C-222DEE4C7358}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetic Ketoacidosis (DKA) </span> Diabetic ketoacidosis (DKA) is an acute metabolic complication of diabetes characterized by hyperglycemia, hyperketonemia, and metabolic acidosis. Hyperglycemia causes an osmotic diuresis with... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (DKA) in patients with either type 1 or type 2 diabetes, and ketoacidosis may occur at lower blood glucose levels than in other causes of DKA. Diagnosis of euglycemic DKA caused by SGLT-2 inhibitors is often delayed due to lower blood sugars. One large study showed an increase in lower limb amputation with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>canagliflozin</span> (<a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84916176" data-toggle="tooltip" title="Oral antihyperglycemic medications reference" data-id="7b6c0741-ba05-4107-85be-b4c88f60f131" data-itemid="912a66b5-650e-4099-a978-4c78e044364d">1</a><span id="7b6c0741-ba05-4107-85be-b4c88f60f131" class="d-none xref"> <span class="tooltip-container"> <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84916176"> <span class="tooltip-content"> <span class="tooltip-heading"> Oral antihyperglycemic medications reference </span> General treatment of diabetes mellitus for all patients involves lifestyle changes, including diet and exercise. Appropriate monitoring and control of blood glucose levels is essential to prevent... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div> </div> </section> <section id="v29300307" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29300308" class="anchor"></span> Dopamine agonist </h3> <div class="topic__content"> <span id="v29300309" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bromocriptine</span> is a <span class="genericDrug" data-showrollover="false">dopamine</span> agonist that lowers hemoglobin A1C about 0.5% by an unknown mechanism. Although approved for type 2 diabetes, it is not commonly used because of potential adverse effects.</p></div> </div> </section> <section id="v84916175" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v84916176" class="anchor"></span> Oral antihyperglycemic medications reference </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84916179" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/28605608/">Neal B, Perkovic V, Mahaffey KW, et al</a>. <span class="genericDrug" data-showrollover="false">Canagliflozin</span> and Cardiovascular and Renal Events in Type 2 Diabetes. <i>N Engl J Med</i> 2017;377(7):644-657. doi:10.1056/NEJMoa1611925</p></div></li></ul></div> </div> </section> </div> </section> <section id="v29300310" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v29300311" class="anchor"></span> Injectable Antihyperglycemic Medications </h2> <div class="topic__content"> <span id="v29300312" class="anchor"></span><div class="para"> <p>Injectable antihyperglycemic medications other than <span class="genericDrug" data-showrollover="false">insulin</span> are the <span class="genericDrug" data-showrollover="false">glucagon</span>-like peptide-1 (GLP-1) receptor agonists, dual glucose-dependent insulinotropic polypeptide (GIP) and <span class="genericDrug" data-showrollover="false">glucagon</span>-like peptide-1 (GLP-1) receptor agonist (dual incretin agonists), and the amylin analog <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pramlintide</span> (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"dc414551-81c5-40f8-9c3b-9db1d1ec857d","Title":"Characteristics%20of%20Injectable%20Non-%20Antihyperglycemic%20Medications","ShareUrlTitle":"characteristics-of-injectable-non-antihyperglycemic-medications","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v84915547","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ECharacteristics%20of%20Injectable%20Non-%3Cspan%20class%3D%27disableDrug%27%20tabindex%3D%270%27%20role%3D%27link%27%20onclick%3D%27javascript%3Avoid%280%29%3B%27%3EInsulin%3C%2Fspan%3E%20Antihyperglycemic%20Medications%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). These medications are used alone or in combination with other antihyperglycemics.</p></div> <section id="v29300315" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29300316" class="anchor"></span> <span class="genericDrug" data-showrollover="false">Glucagon</span>-like peptide-1 (GLP-1) receptor agonists </h3> <div class="topic__content"> <span id="v29300317" class="anchor"></span><div class="para"> <p>GLP-1 receptor agonists mimic the effects of GLP-1, a peptide made in the small intestine that enhances glucose-dependent <span class="genericDrug" data-showrollover="false">insulin</span> secretion and slows gastric emptying. GLP-1 agonists may also reduce appetite and promote weight loss and stimulate beta-cell proliferation. Examples include <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>exenatide</span> (an incretin hormone), <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>lixisenatide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>liraglutide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>dulaglutide</span>, albiglutide, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>semaglutide</span>. Formulations are available for dosing twice a day, once a day, and weekly. All GLP-1 agonists are given as subcutaneous injections, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>semaglutide</span> is also available in oral form. </p></div><span id="v84916184" class="anchor"></span><div class="para"> <p>The most common adverse effects of GLP-1 agonists are gastrointestinal, especially nausea and vomiting. GLP-1 agonists also cause a slight increase in the risk of <a href="./{133C73BA-6613-4F84-BFB4-DC4A1367BB58}.html" data-toggle="tooltip" title="Overview of Pancreatitis" data-id="713ae231-99b1-4976-b7e7-bf0c7af7e6a7" data-itemid="133c73ba-6613-4f84-bfb4-dc4a1367bb58">pancreatitis</a><span id="713ae231-99b1-4976-b7e7-bf0c7af7e6a7" class="d-none xref"> <span class="tooltip-container"> <a href="./{133C73BA-6613-4F84-BFB4-DC4A1367BB58}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Pancreatitis </span> Pancreatitis is classified as either acute or chronic. Acute pancreatitis is inflammation that resolves both clinically and histologically. Chronic pancreatitis is characterized by histologic... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. They are contraindicated in patients with a personal or family history of <a href="./{CE30097C-68D2-442F-B111-4939B59B36DF}.html#v27306815" data-toggle="tooltip" title="Medullary Thyroid Carcinoma" data-id="65140fdb-3187-4dd5-a1fc-935ab80a6c0e" data-itemid="ce30097c-68d2-442f-b111-4939b59b36df">medullary thyroid cancer</a><span id="65140fdb-3187-4dd5-a1fc-935ab80a6c0e" class="d-none xref"> <span class="tooltip-container"> <a href="./{CE30097C-68D2-442F-B111-4939B59B36DF}.html#v27306815"> <span class="tooltip-content"> <span class="tooltip-heading"> Medullary Thyroid Carcinoma </span> Thyroid cancer can derive from follicular cells or parafollicular C-cells. Most thyroid cancers manifest as asymptomatic nodules. Diagnosis is often by fine-needle aspiration biopsy but may... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> because an increased risk of this cancer has occurred in tested rodents. </p></div> </div> </section> <section id="v71803197" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v71803198" class="anchor"></span> Dual incretin agonists (glucose-dependent insulinotropic polypeptide (GIP)/ <span class="genericDrug" data-showrollover="false">glucagon</span>-like peptide-1 (GLP-1) receptor agonist) </h3> <div class="topic__content"> <span id="v71803199" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tirzepatide</span>, a GIP/ GLP1 receptor agonist, is available for the treatment of type 2 diabetes. It is a peptide that acts as a receptor agonist for the GIP and GLP1 receptors. GIP and GLP-1 are incretins that are produced in the small intestine. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tirzepatide</span> increases glucose-dependent <span class="genericDrug" data-showrollover="false">insulin</span> secretion, decreases <span class="genericDrug" data-showrollover="false">glucagon</span> secretion, and slows gastric emptying. It also decreases appetite and induces weight loss. </p></div> <span id="v84915546"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v84915548"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"dc414551-81c5-40f8-9c3b-9db1d1ec857d","Title":"Characteristics%20of%20Injectable%20Non-%20Antihyperglycemic%20Medications","ShareUrlTitle":"characteristics-of-injectable-non-antihyperglycemic-medications","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v84915547","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Characteristics%20of%20Injectable%20Non-%20Antihyperglycemic%20Medications","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="dc414551-81c5-40f8-9c3b-9db1d1ec857d"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'dc414551-81c5-40f8-9c3b-9db1d1ec857d' }, async: true, success: function (data) { $('#dc414551-81c5-40f8-9c3b-9db1d1ec857d').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> </div> </section> <section id="v29300321" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29300322" class="anchor"></span> Amylin analog </h3> <div class="topic__content"> <span id="v29300323" class="anchor"></span><div class="para"> <p>The <span class="genericDrug" data-showrollover="false">amylin</span> analog <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pramlintide</span> mimics amylin, a pancreatic beta-cell hormone that helps regulate postprandial glucose levels. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pramlintide</span> suppresses postprandial <span class="genericDrug" data-showrollover="false">glucagon</span> secretion, slows gastric emptying, and promotes satiety. It is given by injection and is used in combination with mealtime <span class="genericDrug" data-showrollover="false">insulin</span>. Patients with type 1 diabetes are given 30 to 60 mcg subcutaneously before meals, and those with type 2 diabetes are given 120 mcg.</p></div> </div> </section> </div> </section> <section id="v84916192" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v84916193" class="anchor"></span> Disease-Modifying Medications for Diabetes </h2> <div class="topic__content"> <span id="v84916194" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Teplizumab</span>, an anti-CD3 monoclonal antibody, is a disease-modifying medication for type 1 diabetes. It <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html#v989236" data-toggle="tooltip" title="Prevention" data-id="870fd385-6e18-4ee8-a3e7-1f855a07dcfc" data-itemid="c638b386-4b60-444c-8a50-bd90e6b9d85d">delays clinical type 1 diabetes</a><span id="870fd385-6e18-4ee8-a3e7-1f855a07dcfc" class="d-none xref"> <span class="tooltip-container"> <a href="./{C638B386-4B60-444C-8A50-BD90E6B9D85D}.html#v989236"> <span class="tooltip-content"> <span class="tooltip-heading"> Prevention </span> Diabetes mellitus is impaired insulin secretion and variable degrees of peripheral insulin resistance leading to hyperglycemia. Early symptoms are related to hyperglycemia and include polydipsia... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> in at-risk individuals. It is only used in patients with confirmed type 1 stage 2 (dysglycemia without overt symptoms of hyperglycemia and at least 2 positive autoantibodies for type 1 diabetes). It is given as an intravenous infusion daily for 14 days and had been shown to delay the onset of symptomatic type 1 diabetes for an average of 2 years (<a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84916198" data-toggle="tooltip" title="Disease-modifying medications references" data-id="ce8f21a0-e6dc-45d1-8610-e325095d7428" data-itemid="912a66b5-650e-4099-a978-4c78e044364d">1, 2</a><span id="ce8f21a0-e6dc-45d1-8610-e325095d7428" class="d-none xref"> <span class="tooltip-container"> <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84916198"> <span class="tooltip-content"> <span class="tooltip-heading"> Disease-modifying medications references </span> General treatment of diabetes mellitus for all patients involves lifestyle changes, including diet and exercise. Appropriate monitoring and control of blood glucose levels is essential to prevent... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Adverse effects include cytokine release syndrome manifested by fever, nausea, fatigue, headache, myalgia, arthralgia, and elevated liver enzymes. Other serious adverse effects include lymphopenia and hypersensitivity. </p></div> <section id="v84916197" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v84916198" class="anchor"></span> Disease-modifying medications references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84916201" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31180194/">Herold KC, Bundy BN, Long SA, et al</a>. An Anti-CD3 Antibody, <span class="genericDrug" data-showrollover="false">Teplizumab</span>, in Relatives at Risk for Type 1 Diabetes [published correction appears in <i>N Engl J Med</i> 2020 Feb 6;382(6):586]. <i>N Engl J Med</i> 2019;381(7):603-613. doi:10.1056/NEJMoa1902226</p></div></li><li class="topic__listitem"><span id="v84916205" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/33658358/">Sims EK, Bundy BN, Stier K, et al</a>. <span class="genericDrug" data-showrollover="false">Teplizumab</span> improves and stabilizes beta cell function in antibody-positive high-risk individuals. <i>Sci Transl Med</i> 2021;13(583):eabc8980. doi:10.1126/scitranslmed.abc8980</p></div></li></ul></div> </div> </section> </div> </section> <section id="v29300418" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v29300419" class="anchor"></span> Adjunctive Medications for Diabetes </h2> <div class="topic__content"> <span id="v29300420" class="anchor"></span><div class="para"> <p>Pharmacologic measures to prevent or treat <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html" data-toggle="tooltip" title="Complications of Diabetes Mellitus" data-id="cdcd9781-497b-44bd-822e-c605cc943509" data-itemid="ec552a1a-fa57-4ab9-a8da-ce820d465c83">complications of diabetes mellitus</a><span id="cdcd9781-497b-44bd-822e-c605cc943509" class="d-none xref"> <span class="tooltip-container"> <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Complications of Diabetes Mellitus </span> In patients with diabetes mellitus, years of poorly controlled hyperglycemia lead to multiple, primarily vascular, complications that affect small vessels (microvascular), large vessels (macrovascular)... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/9/6/496-cellulitis-with-foot-ulcer-slide-98a-springer-crop-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Complications of Diabetes Mellitus" loading="lazy"> </span> </a> </span> </span> (<a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v29300436" data-toggle="tooltip" title="Adjunctive medications references" data-id="94e65749-0245-49ff-b52e-f483e7ee3b88" data-itemid="912a66b5-650e-4099-a978-4c78e044364d">1, 2, 3</a><span id="94e65749-0245-49ff-b52e-f483e7ee3b88" class="d-none xref"> <span class="tooltip-container"> <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v29300436"> <span class="tooltip-content"> <span class="tooltip-heading"> Adjunctive medications references </span> General treatment of diabetes mellitus for all patients involves lifestyle changes, including diet and exercise. Appropriate monitoring and control of blood glucose levels is essential to prevent... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>) are critical, including </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29300425" class="anchor"></span><div class="para"> <p>Angiotensin-converting enzyme (ACE) inhibitors or <span class="genericDrug" data-showrollover="false">angiotensin II</span> receptor blockers (ARBs)</p></div></li><li class="topic__listitem"><span id="v29300427" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Aspirin</span></p></div></li><li class="topic__listitem"><span id="v29300429" class="anchor"></span><div class="para"> <p>Statins</p></div></li></ul></div><span id="v29300430" class="anchor"></span><div class="para"> <p><b>ACE inhibitors or ARBs</b> are indicated for patients with evidence of early <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html#v29299332" data-toggle="tooltip" title="Diabetic Nephropathy" data-id="758cc336-8a61-4e21-86cf-374febee3250" data-itemid="ec552a1a-fa57-4ab9-a8da-ce820d465c83">diabetic nephropathy</a><span id="758cc336-8a61-4e21-86cf-374febee3250" class="d-none xref"> <span class="tooltip-container"> <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html#v29299332"> <span class="tooltip-content"> <span class="tooltip-heading"> Diabetic Nephropathy </span> In patients with diabetes mellitus, years of poorly controlled hyperglycemia lead to multiple, primarily vascular, complications that affect small vessels (microvascular), large vessels (macrovascular)... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/9/6/496-cellulitis-with-foot-ulcer-slide-98a-springer-crop-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diabetic Nephropathy" loading="lazy"> </span> </a> </span> </span> (albuminuria), even in the absence of hypertension, and are a good choice for treating hypertension in patients who have diabetes mellitus and who have not yet shown renal impairment.</p></div><span id="v29300432" class="anchor"></span><div class="para"> <p>ACE inhibitors prevent cardiovascular events in patients with diabetes mellitus. Treatment with an ACE inhibitor or ARB is recommended in patients with known atherosclerotic cardiovascular disease (ASCVD) for secondary prevention.</p></div><span id="v29300433" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Aspirin</span></b> 81 to 325 mg once a day provides cardiovascular protection. <span class="genericDrug" data-showrollover="false">Aspirin</span> is recommended for secondary prevention in all patients with a history of ASCVD. The benefits of <span class="genericDrug" data-showrollover="false">aspirin</span> in patients without established cardiovascular disease (ie, for primary prevention) are less clear. <span class="genericDrug" data-showrollover="false">Aspirin</span> might be considered for primary prevention in patients with diabetes who are ≥ 50 years of age and have at least one additional <a href="./{2E89ECA0-4144-42F5-A042-99D82FF08250}.html#v933715" data-toggle="tooltip" title="Risk Factors" data-id="5382f874-dd73-47bb-a481-e856ddd98e3f" data-itemid="2e89eca0-4144-42f5-a042-99d82ff08250">risk factor for ASCVD</a><span id="5382f874-dd73-47bb-a481-e856ddd98e3f" class="d-none xref"> <span class="tooltip-container"> <a href="./{2E89ECA0-4144-42F5-A042-99D82FF08250}.html#v933715"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk Factors </span> Atherosclerosis is characterized by patchy intimal plaques (atheromas) that encroach on the lumen of medium-sized and large arteries. The plaques contain lipids, inflammatory cells, smooth muscle... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/1/7/m1750135-atherosclerotic-plaque-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk Factors" loading="lazy"> </span> </a> </span> </span> and are not at increased risk of bleeding. In patients > 70 years, risk of bleeding may outweigh benefits of primary prevention. </p></div><span id="v29300434" class="anchor"></span><div class="para"> <p><b>Statins</b> are recommended for all patients with diabetes 40 to 75 years of age (<a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v29300436" data-toggle="tooltip" title="Adjunctive medications references" data-id="80555c96-c1dd-4861-80eb-296fb07a3e0c" data-itemid="912a66b5-650e-4099-a978-4c78e044364d">3</a><span id="80555c96-c1dd-4861-80eb-296fb07a3e0c" class="d-none xref"> <span class="tooltip-container"> <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v29300436"> <span class="tooltip-content"> <span class="tooltip-heading"> Adjunctive medications references </span> General treatment of diabetes mellitus for all patients involves lifestyle changes, including diet and exercise. Appropriate monitoring and control of blood glucose levels is essential to prevent... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Moderate- to high-intensity treatment is used, and a high-intensity statin (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atorvastatin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rosuvastatin</span>) is recommended for patients at higher ASCVD risk. For all patients with diabetes and established ASCVD or at very high risk for ASCVD, it is also reasonable to target a low-density lipoprotein (LDL) cholesterol level <span class='symbol'>&lt</span> 70 mg/dL (1.81 mol/L) with maximally tolerated statin and addition of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ezetimibe</span> or a proprotein convertase subtilisin/kexin type 9 (PCSK -9) inhibitor if necessary. In addition, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ezetimibe</span> or PCSK-9 inhibitor therapy should be used in patients who are intolerant of statin therapy (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"25aa7f27-d15c-4405-b26f-e168117d5f61","Title":"Statins%20For%20ASCVD%20Prevention","ShareUrlTitle":"statins-for-ascvd-prevention","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55564932","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EStatins%20for%20ASCVD%20Prevention%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). For patients < 40 years or > 75 years, statins are given based upon individual assessment of the risk:benefit ratio and patient preference. Patients with type 2 diabetes mellitus tend to have high levels of triglycerides and small, dense LDL cholesterol and low levels of HDL cholesterol; they should receive aggressive treatment. The latest recommendation from the American Diabetes Association suggests a target LDL <span class='symbol'>&lt</span> 55 mg/dL (1.42 mmol/L) (<a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v29300436" data-toggle="tooltip" title="Adjunctive medications references" data-id="a6702816-ea7e-4b29-b219-4588e6f8c749" data-itemid="912a66b5-650e-4099-a978-4c78e044364d">4</a><span id="a6702816-ea7e-4b29-b219-4588e6f8c749" class="d-none xref"> <span class="tooltip-container"> <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v29300436"> <span class="tooltip-content"> <span class="tooltip-heading"> Adjunctive medications references </span> General treatment of diabetes mellitus for all patients involves lifestyle changes, including diet and exercise. Appropriate monitoring and control of blood glucose levels is essential to prevent... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> ).</p></div> <section id="v29300435" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v29300436" class="anchor"></span> Adjunctive medications references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v29300439" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="http://care.diabetesjournals.org/content/38/9/1777.long">Fox CS, Golden SH, Anderson C, et al</a>: AHA/ ADA Scientific Statement: Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence. <i>Circulation</i> 132: 691–718, 2015.</p></div></li><li class="topic__listitem"><span id="v49788337" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/32022600/">Garber AJ, Handelsman Y, Grunberger G, et al</a>: Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm--2020 executive summary. <i>Endocrine Practice</i> 26:107–139, 2020.</p></div></li><li class="topic__listitem"><span id="v71803202" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/30423391/">Grundy SM, Stone NJ, Bailey AL, et al</a>: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. <i>J Am Coll Cardiol</i> 73(24):3168–3209, 2019. doi: 10.1016/j.jacc.2018.11.002</p></div></li><li class="topic__listitem"><span id="v84916216" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://diabetesjournals.org/care/issue/46/Supplement_1">American Diabetes Association: Standards of Medical Care in Diabetes</a><i>Diabetes Care</i> 46 (Supplement 1): 1-291, 2023.</p></div></li></ul></div> </div> </section> </div> </section> <section id="v49788340" class="topic__section FHead"> <h2 id="Further_v49788341" class="topic__header--section"> <span id="v49788341" class="anchor"></span> More Information </h2> <div class="topic__content"> <span id="v71803204" class="anchor"></span><div class="para"> <p>The following English-language resources may be useful. Please note that THE MANUAL is not responsible for the content of these resources.</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v49788344" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://diabetesjournals.org/care/issue/46/Supplement_1">American Diabetes Association: Standards of Medical Care in Diabetes.</a><i>Diabetes Care</i> 46 (Supplement 1): 1-291, 2023.</p></div></li><li class="topic__listitem"><span id="v84916219" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/36148880/">Davies MJ, Aroda VR, Collins BS, et al</a>. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). <i>Diabetes Care</i> 2022;45(11):2753-2786. doi:10.2337/dci22-0034</p></div></li><li class="topic__listitem"><span id="v49788350" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://www.endocrine.org/clinical-practice-guidelines/diabetes-mellitus-and-glucose-metabolism">Endocrine Society: Clinical Practice Guidelines</a>: provides guidelines on evaluation and management of patients with diabetes as well as links to other information for clinicians</p></div></li><li class="topic__listitem"><span id="v84916222" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/32513817/">Powers MA, Bardsley JK, Cypress M, et al</a>. Diabetes Self-management Education and Support in Adults With Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association. <i>Diabetes Care</i> 2020;43(7):1636-1649. doi:10.2337/dci20-0023</p></div></li><li class="topic__listitem"><span id="v71803206" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/35997723/">US Preventive Services Task Force, Mangione CM, Barry MJ, et al</a>: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. <i>JAMA</i> 328(8):746–753, 2022. doi:10.1001/jama.2022.13044</p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="250;MM806;MM807;MM1073">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: '250;MM806;MM807;MM1073',
 title: 'Medications for Diabetes Mellitus Treatment',
 itemGuid: '912a66b5-650e-4099-a978-4c78e044364d'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{EC552A1A-FA57-4AB9-A8DA-CE820D465C83}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Complications of Diabetes Mellitus</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{F81143FB-A7CE-4C85-913C-222DEE4C7358}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Diabetic Ketoacidosis (DKA)</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="f97a8d70-5df2-4fa4-80bd-008907f3ee2a_mobile" usemap="#f97a8d70-5df2-4fa4-80bd-008907f3ee2a_mobile" width="326" height="90">
 <map name="f97a8d70-5df2-4fa4-80bd-008907f3ee2a_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="f97a8d70-5df2-4fa4-80bd-008907f3ee2a_tablet" usemap="#f97a8d70-5df2-4fa4-80bd-008907f3ee2a_tablet" width="326" height="90">
 <map name="f97a8d70-5df2-4fa4-80bd-008907f3ee2a_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="f97a8d70-5df2-4fa4-80bd-008907f3ee2a_desktop" usemap="#f97a8d70-5df2-4fa4-80bd-008907f3ee2a_desktop" width="326" height="90">
 <map name="f97a8d70-5df2-4fa4-80bd-008907f3ee2a_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd01
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="912A66B5650E4099A9784C78E044364D">
<div id="hiddentblcontents" style="display:none"><div id='hidden_v84915547'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v84915548"></span> <div class="TableFullPage" id="v84915547"> <h3 class="title">Characteristics of Injectable Non- Antihyperglycemic Medications</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v84915556" class="anchor"></span><div class="para"> <p>Generic Name</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v84915559" class="anchor"></span><div class="para"> <p>Comments</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915572" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Glucagon</span>-like peptide-1 (GLP-1) agonists</p></div></p></td><td><span id="v84915575" class="anchor"></span><div class="para"> <p>Low risk of hypoglycemia; may promote modest weight loss</p></div><span id="v84915576" class="anchor"></span><div class="para"> <p>Increased risk of pancreatitis</p></div><span id="v84915577" class="anchor"></span><div class="para"> <p>Thyroid C-cell tumors (medullary carcinoma) noted in rodents</p></div><span id="v84915578" class="anchor"></span><div class="para"> <p>To minimize nausea and vomiting, start at the lowest dose and titrate according to manufacturer's recommendations </p></div><span id="v84915579" class="anchor"></span><div class="para"> <p>May improve hepatic fat content and fibrosis, MASLD, and MASH</p></div></td></tr><tr class="even"><td><span id="v84915582" class="anchor"></span><div class="para"> <p>Albiglutide</p></div></td><td><span id="v84915584" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd"><td><span id="v84915587" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dulaglutide</span> </p></div></td><td><span id="v84915589" class="anchor"></span><div class="para"> <p>May decrease major adverse cardiovascular events in patients with high risk of cardiovascular disease</p></div></td></tr><tr class="even"><td><span id="v84915592" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Exenatide</span></p></div></td><td><span id="v84915594" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd"><td><span id="v84915597" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Exenatide</span>, once a week</p></div></td><td><span id="v84915599" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915602" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Liraglutide</span></p></div></td><td><span id="v84915604" class="anchor"></span><div class="para"> <p>May decrease major adverse cardiovascular events and cardiovascular death in patients with high risk of cardiovascular disease</p></div></td></tr><tr class="odd"><td><span id="v84915607" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lixisenatide</span></p></div></td><td><span id="v84915609" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915612" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Semaglutide</span>*</p></div></td><td><span id="v84915614" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Semaglutide</span> is associated with increased progression of diabetic retinopathy</p></div><span id="v84915616" class="anchor"></span><div class="para"> <p>May decrease major adverse cardiovascular events and cardiovascular death (oral <span class="genericDrug" data-showrollover="false">semaglutide</span>) in patients with high risk of cardiovascular disease</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915621" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Amylin</span> analog</p></div></p></td><td><span id="v84915624" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v84915627" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pramlintide</span></p></div></td><td><span id="v84915629" class="anchor"></span><div class="para"> <p>For use in combination with <span class="genericDrug" data-showrollover="false">insulin</span>, but injected using a separate syringe</p></div><span id="v84915631" class="anchor"></span><div class="para"> <p>May need to adjust <span class="genericDrug" data-showrollover="false">insulin</span> dose to avoid hypoglycemia</p></div><span id="v84915633" class="anchor"></span><div class="para"> <p>Nausea common but declining with time</p></div><span id="v84915634" class="anchor"></span><div class="para"> <p>May promote modest weight loss</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915638" class="anchor"></span><div class="para"> <p>Dual incretin agonists (glucose-dependent insulinotropic polypeptide (GIP)/<span class="genericDrug" data-showrollover="false">glucagon</span>-like peptide-1 (GLP-1) receptor agonist</p></div></p></td><td><span id="v84915640" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v84915643" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tirzepatide</span></p></div></td><td><span id="v84915645" class="anchor"></span><div class="para"> <p>Promotes weight loss</p></div><span id="v84915646" class="anchor"></span><div class="para"> <p>Causes GI symptoms, including decreased appetite, diarrhea , nausea, abdominal pain and increased amylase and lipase</p></div><span id="v84915647" class="anchor"></span><div class="para"> <p>To minimize symptoms start at lowest dose and titrate according to manufacturers recommendations</p></div><span id="v84915648" class="anchor"></span><div class="para"> <p>Thyroid C cell tumors noted in rodents</p></div><span id="v84915649" class="anchor"></span><div class="para"> <p>Cases of pancreatitis have been reported</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v84915563" class="anchor"></span><div class="para"> <p>* Also available in an oral form. See table <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84915274" data-toggle="tooltip" title="Characteristics of Oral Antihyperglycemics" data-id="01b05f51-77f0-4493-908b-b04db5a9b208" data-itemid="912a66b5-650e-4099-a978-4c78e044364d">Characteristics of Oral Antihyperglycemics</a><span id="01b05f51-77f0-4493-908b-b04db5a9b208" class="d-none xref"> <span class="tooltip-container"> <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84915274"> <span class="tooltip-content"> <span class="tooltip-heading"> Characteristics of Oral Antihyperglycemics </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="/Content/Images/Redesign/table/icon_table_red.png?mh=160&mw=160" class="tooltip-Preview" alt="Characteristics of Oral Antihyperglycemics" loading="lazy"> </span> </a> </span> </span> for information.</p></div></td></tr><tr><td colspan="2"><span id="v84915567" class="anchor"></span><div class="para"> <p>GI <span class='symbol'>=</span> gastrointestinal; MASLD <span class='symbol'>=</span> metabolic dysfunction-associated steatotic liver disease; MASH <span class='symbol'>=</span> metabolic dysfunction-associated steatohepatitis.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v84915273'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v84915274"></span> <div class="TableFullPage" id="v84915273"> <h3 class="title">Characteristics of Oral Antihyperglycemics</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v84915282" class="anchor"></span><div class="para"> <p>Generic Name</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v84915285" class="anchor"></span><div class="para"> <p>Comments</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915305" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> secretagogues: Long-acting (sulfonylureas)</p></div></p></td><td><span id="v84915308" class="anchor"></span><div class="para"> <p>Augment pancreatic beta-cell <span class="genericDrug" data-showrollover="false">insulin</span> secretion</p></div><span id="v84915310" class="anchor"></span><div class="para"> <p>Can be used alone or in combination with <span class="genericDrug" data-showrollover="false">insulin</span> and other medications</p></div><span id="v84915312" class="anchor"></span><div class="para"> <p>Their long duration of action may lead to serious hypoglycemia, especially in older patients</p></div><span id="v84915313" class="anchor"></span><div class="para"> <p>Efficacy may wane after 5 years of use</p></div></td></tr><tr class="even"><td><span id="v84915316" class="anchor"></span><div class="para"> <p>Acetohexamide*</p></div></td><td><span id="v84915318" class="anchor"></span><div class="para"> <p>Not available in the United States</p></div></td></tr><tr class="odd"><td><span id="v84915321" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chlorpropamide</span>*</p></div></td><td><span id="v84915323" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Chlorpropamide</span>: May cause <a href="./{ED55B7A6-31FA-4DD1-B5C1-FA91E08A131D}.html" data-toggle="tooltip" title="Hyponatremia" data-id="c28133ec-5b43-45ff-82a7-73f56b9d50b3" data-itemid="ed55b7a6-31fa-4dd1-b5c1-fa91e08a131d">hyponatremia</a><span id="c28133ec-5b43-45ff-82a7-73f56b9d50b3" class="d-none xref"> <span class="tooltip-container"> <a href="./{ED55B7A6-31FA-4DD1-B5C1-FA91E08A131D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hyponatremia </span> Hyponatremia is decrease in serum sodium concentration < 136 mEq/L (< 136 mmol/L) caused by an excess of water relative to solute. Common causes include diuretic use, diarrhea, heart failure... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and flushing after <span class="genericDrug" data-showrollover="false">alcohol</span> ingestion</p></div></td></tr><tr class="even"><td><span id="v84915328" class="anchor"></span><div class="para"> <p>Tolazamide*</p></div></td><td><span id="v84915330" class="anchor"></span><div class="para"> <p>Not available in the United States</p></div></td></tr><tr class="odd"><td><span id="v84915333" class="anchor"></span><div class="para"> <p>Tolbutamide*</p></div></td><td><span id="v84915335" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915338" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Glyburide</span>, regular-release†</p></div></td><td><span id="v84915340" class="anchor"></span><div class="para"> <p>No evidence of increased effectiveness of doses > 10 mg/day</p></div></td></tr><tr class="odd"><td><span id="v84915343" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Glyburide</span>, micronized†</p></div></td><td><span id="v84915345" class="anchor"></span><div class="para"> <p> No evidence of increased effectiveness of doses > 10 mg/day</p></div></td></tr><tr class="even"><td><span id="v84915348" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Glipizide</span>, regular-release†</p></div></td><td><span id="v84915350" class="anchor"></span><div class="para"> <p> No evidence of increased effectiveness of doses > 10 mg/day</p></div></td></tr><tr class="odd"><td><span id="v84915353" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Glipizide</span>, extended-release†</p></div></td><td><span id="v84915355" class="anchor"></span><div class="para"> <p> No evidence of increased effectiveness of doses > 10 mg/day</p></div></td></tr><tr class="even"><td><span id="v84915358" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Glimepiride</span>†</p></div></td><td><span id="v84915360" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915364" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> secretagogues: Short-acting (meglitinides)</p></div></p></td><td><span id="v84915367" class="anchor"></span><div class="para"> <p>Augment pancreatic beta-cell <span class="genericDrug" data-showrollover="false">insulin</span> secretion</p></div><span id="v84915369" class="anchor"></span><div class="para"> <p>Can be used alone or in combination with other oral medications and <span class="genericDrug" data-showrollover="false">insulin</span></p></div></td></tr><tr class="even"><td><span id="v84915373" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Nateglinide</span></p></div></td><td><span id="v84915375" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd"><td><span id="v84915378" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Repaglinide</span></p></div></td><td><span id="v84915380" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even" tablehead2=""><td><p class="tableHead2"><span id="v84915384" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> sensitizers: Biguanides</p></div></p></td><td><span id="v84915387" class="anchor"></span><div class="para"> <p>Augment suppression of hepatic glucose production by <span class="genericDrug" data-showrollover="false">insulin</span></p></div><span id="v84915389" class="anchor"></span><div class="para"> <p>Can be used alone or in combination with other oral medications and <span class="genericDrug" data-showrollover="false">insulin</span></p></div><span id="v84915391" class="anchor"></span><div class="para"> <p>Major adverse effects: <a href="./{D14FD7DA-5C9F-4CC9-B0CC-F79C4E61D23E}.html" data-toggle="tooltip" title="Lactic Acidosis" data-id="0e560814-c89f-4b9c-90de-e9f03e691278" data-itemid="d14fd7da-5c9f-4cc9-b0cc-f79c4e61d23e">Lactic acidosis</a><span id="0e560814-c89f-4b9c-90de-e9f03e691278" class="d-none xref"> <span class="tooltip-container"> <a href="./{D14FD7DA-5C9F-4CC9-B0CC-F79C4E61D23E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Lactic Acidosis </span> Lactic acidosis is a high anion gap metabolic acidosis due to elevated blood lactate. Lactic acidosis results from overproduction of lactate, decreased metabolism of lactate, or both. (See also... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (rare)</p></div><span id="v84915393" class="anchor"></span><div class="para"> <p>Contraindicated in at-risk patients, including those with renal insufficiency, metabolic acidosis, hypoxia, alcohol use disorder, or dehydration</p></div><span id="v84915394" class="anchor"></span><div class="para"> <p>Do not cause hypoglycemia</p></div><span id="v84915395" class="anchor"></span><div class="para"> <p>Other adverse effects: Gastrointestinal distress (diarrhea, nausea, pain), <span class="genericDrug" data-showrollover="false">vitamin B12</span> malabsorption</p></div><span id="v84915397" class="anchor"></span><div class="para"> <p>Potentiate weight loss</p></div><span id="v84915398" class="anchor"></span><div class="para"> <p>Should be stopped temporarily before radiologic procedures requiring use of contrast agents</p></div></td></tr><tr class="odd"><td><span id="v84915401" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Metformin</span>, regular-release</p></div></td><td><span id="v84915403" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915406" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Metformin</span>, extended-release</p></div></td><td><span id="v84915408" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915412" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> sensitizers: Thiazolidinediones</p></div></p></td><td><span id="v84915415" class="anchor"></span><div class="para"> <p>Augment suppression of hepatic glucose production by <span class="genericDrug" data-showrollover="false">insulin</span> and increase <span class="genericDrug" data-showrollover="false">insulin</span> sensitivity in muscle and adipose tissue</p></div><span id="v84915418" class="anchor"></span><div class="para"> <p>Can be used alone or in combination with other oral medications and <span class="genericDrug" data-showrollover="false">insulin</span></p></div><span id="v84915420" class="anchor"></span><div class="para"> <p>Major adverse effects: Weight gain, fluid retention, anemia (mild)</p></div><span id="v84915421" class="anchor"></span><div class="para"> <p>Hepatotoxicity rare, but liver monitoring required</p></div></td></tr><tr class="even"><td><span id="v84915424" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pioglitazone</span></p></div></td><td><span id="v84915426" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Pioglitazone</span>: May increase risk of bladder cancer, heart failure, and fractures</p></div></td></tr><tr class="odd"><td><span id="v84915430" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rosiglitazone</span></p></div></td><td><span id="v84915432" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Rosiglitazone</span>: May increase low-density lipoprotein cholesterol and may increase risk of heart failure, angina, myocardial infarction, stroke, and fractures</p></div></td></tr><tr class="even" tablehead2=""><td><p class="tableHead2"><span id="v84915437" class="anchor"></span><div class="para"> <p>Alpha-glucosidase inhibitors</p></div></p></td><td><span id="v84915439" class="anchor"></span><div class="para"> <p>Intestinal enzyme inhibitors</p></div><span id="v84915440" class="anchor"></span><div class="para"> <p>Used as monotherapy or combination therapy with other oral medications or <span class="genericDrug" data-showrollover="false">insulin</span> to decrease postprandial plasma glucose levels</p></div><span id="v84915442" class="anchor"></span><div class="para"> <p>Must be taken with the first bite of meal</p></div><span id="v84915443" class="anchor"></span><div class="para"> <p>Gastrointestinal adverse effects (flatulence, diarrhea, bloating) common but may decrease over time</p></div><span id="v84915444" class="anchor"></span><div class="para"> <p>Start with small dose (25 mg/day) and gradually titrate over several weeks</p></div></td></tr><tr class="odd"><td><span id="v84915447" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Acarbose</span></p></div></td><td><span id="v84915449" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915452" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Miglitol</span></p></div></td><td><span id="v84915454" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915458" class="anchor"></span><div class="para"> <p>Dipeptidyl peptidase-4 (DPP4) inhibitors</p></div></p></td><td><span id="v84915460" class="anchor"></span><div class="para"> <p>Inhibit the enzyme DPP-4, which is involved in the breakdown of GLP-1, a peptide that stimulates <span class="genericDrug" data-showrollover="false">insulin</span> secretion and inhibits <span class="genericDrug" data-showrollover="false">glucagon</span> secretion</p></div><span id="v84915463" class="anchor"></span><div class="para"> <p>All DPP-4 inhibitors can be used in moderate to severe renal insufficiency. All except <span class="genericDrug" data-showrollover="false">linagliptin</span> require dose adjustment for estimated glomerular filtration rate</p></div><span id="v84915465" class="anchor"></span><div class="para"> <p>Well-tolerated but cause only modest improvements in hemoglobin A1C </p></div><span id="v84915466" class="anchor"></span><div class="para"> <p>A slight increase in risk of pancreatitis </p></div></td></tr><tr class="even"><td><span id="v84915469" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Alogliptin</span> </p></div></td><td><span id="v84915471" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd"><td><span id="v84915474" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Linagliptin</span></p></div></td><td><span id="v84915476" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915479" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Saxagliptin</span></p></div></td><td><span id="v84915481" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd"><td><span id="v84915484" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Sitagliptin</span></p></div></td><td><span id="v84915486" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even" tablehead2=""><td><p class="tableHead2"><span id="v84915490" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Glucagon</span>-like peptide-1 (GLP-1) receptor agonists‡</p></div></p></td><td><span id="v84915493" class="anchor"></span><div class="para"> <p>Mimic the effects of GLP-1, a peptide made in the small intestine that enhances glucose-dependent <span class="genericDrug" data-showrollover="false">insulin</span> secretion</p></div></td></tr><tr class="odd"><td><span id="v84915497" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Semaglutide</span>¶</p></div></td><td><span id="v84915499" class="anchor"></span><div class="para"> <p>Low risk of hypoglycemia; may promote modest weight loss</p></div><span id="v84915500" class="anchor"></span><div class="para"> <p>Increased risk of pancreatitis</p></div><span id="v84915501" class="anchor"></span><div class="para"> <p>Thyroid C-cell tumors (medullary carcinoma) noted in rodents</p></div><span id="v84915502" class="anchor"></span><div class="para"> <p>Weekly subcutaneous preparations may cause fewer gastrointestinal adverse effects. When given once or twice a day, lowest starting dose may minimize nausea</p></div><span id="v84915503" class="anchor"></span><div class="para"> <p>Oral <span class="genericDrug" data-showrollover="false">semaglutide</span> may decrease cardiovascular death in patients with high risk of cardiovascular disease </p></div><span id="v84915505" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Semaglutide</span> is associated with increased progression of diabetic retinopathy</p></div></td></tr><tr class="even" tablehead2=""><td><p class="tableHead2"><span id="v84915510" class="anchor"></span><div class="para"> <p>Sodium-glucose co-transporter 2 (SGLT2) inhibitors</p></div></p></td><td><span id="v84915512" class="anchor"></span><div class="para"> <p>Inhibit SGLT-2 in the proximal tubule of the kidney, which blocks glucose reabsorption, thus causing glycosuria</p></div><span id="v84915513" class="anchor"></span><div class="para"> <p>SGLT-2 inhibitors may cause Fournier gangrene, weight loss, orthostatic hypotension, yeast infections, and urinary tract infections </p></div><span id="v84915514" class="anchor"></span><div class="para"> <p>Use cautiously in older adults and in patients with renal impairment </p></div><span id="v84915515" class="anchor"></span><div class="para"> <p>Associated with euglycemic diabetic ketoacidosis. Ketogenic, or low-carbohydrate, diets should be avoided and medications should be stopped several days before procedures or during illness and inability to tolerate oral intake </p></div></td></tr><tr class="odd"><td><span id="v84915518" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bexagliflozin</span></p></div></td><td><span id="v84915520" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915523" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Canagliflozin</span></p></div></td><td><span id="v84915525" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Canagliflozin</span> is associated with a higher rate of limb amputations </p></div><span id="v84915527" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Canagliflozin</span> decreases mortality and heart failure hospitalizations in patients with cardiovascular risk. Decreases progression of chronic kidney disease </p></div></td></tr><tr class="odd"><td><span id="v84915531" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dapagliflozin</span></p></div></td><td><span id="v84915533" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Dapagliflozin</span> decreases mortality and heart failure hospitalizations in patients with cardiovascular risk. Decreases progression of chronic kidney disease</p></div></td></tr><tr class="even"><td><span id="v84915537" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Empagliflozin</span></p></div></td><td><span id="v84915539" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Empagliflozin</span> decreases mortality and heart failure hospitalizations in patients with cardiovascular risk. Decreases progression of chronic kidney disease</p></div></td></tr><tr class="odd"><td><span id="v84915543" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ertugliflozin</span></p></div></td><td><span id="v84915545" class="anchor"></span><div class="para"> <p>—</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v84915289" class="anchor"></span><div class="para"> <p>* First-generation sulfonylureas.</p></div></td></tr><tr><td colspan="2"><span id="v84915292" class="anchor"></span><div class="para"> <p>† 2nd-generation sulfonylureas.</p></div></td></tr><tr><td colspan="2"><span id="v84915295" class="anchor"></span><div class="para"> <p>‡ See table <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84915548" data-toggle="tooltip" title="Characteristics of Injectable Non- Antihyperglycemic Medications" data-id="1b48a7db-5d49-4a71-9c41-103f7e6dd805" data-itemid="912a66b5-650e-4099-a978-4c78e044364d">Characteristics of Injectable Non-<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Insulin</span> Antihyperglycemic Medications</a><span id="1b48a7db-5d49-4a71-9c41-103f7e6dd805" class="d-none xref"> <span class="tooltip-container"> <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84915548"> <span class="tooltip-content"> <span class="tooltip-heading"> Characteristics of Injectable Non- Antihyperglycemic Medications </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="/Content/Images/Redesign/table/icon_table_red.png?mh=160&mw=160" class="tooltip-Preview" alt="Characteristics of Injectable Non- Antihyperglycemic Medications" loading="lazy"> </span> </a> </span> </span> for information on injectable <span class="genericDrug" data-showrollover="false">glucagon</span>-like peptide-1 (GLP-1) receptor agonists.</p></div></td></tr><tr><td colspan="2"><span id="v84915300" class="anchor"></span><div class="para"> <p>¶ Also available in an injectable form. </p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v56218278'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v41829188"></span> <div class="TableFullPage" id="v56218278"> <h3 class="title">Onset, Peak, and Duration of Action of Human Insulin Preparations*</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v56218288" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> Preparation</p></div></th><th style='text-align:left' scope='col'><span id="v56218291" class="anchor"></span><div class="para"> <p>Onset of Action</p></div></th><th style='text-align:left' scope='col'><span id="v56218293" class="anchor"></span><div class="para"> <p>Peak Action</p></div></th><th style='text-align:left' scope='col'><span id="v56218295" class="anchor"></span><div class="para"> <p>Duration of Action</p></div></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218316" class="anchor"></span><div class="para"> <p>Rapid-acting</p></div></p></td></tr><tr class="even"><td><span id="v56218319" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Lispro, aspart, glulisine†</p></div></td><td><span id="v56218321" class="anchor"></span><div class="para"> <p>5–15 minutes</p></div></td><td><span id="v56218323" class="anchor"></span><div class="para"> <p>45–75 minutes</p></div></td><td><span id="v56218325" class="anchor"></span><div class="para"> <p>3–5 hours</p></div></td></tr><tr class="odd"><td><span id="v56218328" class="anchor"></span><div class="para"> <p>Inhaled regular</p></div></td><td><span id="v56218330" class="anchor"></span><div class="para"> <p>< 15=""></p></div></td><td><span id="v56218332" class="anchor"></span><div class="para"> <p>50 minutes</p></div></td><td><span id="v56218334" class="anchor"></span><div class="para"> <p>2–3 hours</p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218338" class="anchor"></span><div class="para"> <p>Short-acting</p></div></p></td></tr><tr class="odd"><td><span id="v56218341" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Regular†</p></div></td><td><span id="v56218343" class="anchor"></span><div class="para"> <p>30–60 minutes</p></div></td><td><span id="v56218345" class="anchor"></span><div class="para"> <p>2–4 hours</p></div></td><td><span id="v56218347" class="anchor"></span><div class="para"> <p>6–8 hours</p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218351" class="anchor"></span><div class="para"> <p>Intermediate-acting</p></div></p></td></tr><tr class="odd"><td><span id="v56218354" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class="genericDrug" data-showrollover="false">Insulin</span> isophane (NPH)‡</p></div></td><td><span id="v56218356" class="anchor"></span><div class="para"> <p>About 2 hours</p></div></td><td><span id="v56218358" class="anchor"></span><div class="para"> <p>4–12 hours</p></div></td><td><span id="v56218360" class="anchor"></span><div class="para"> <p>18–26 hours</p></div></td></tr><tr class="even"><td><span id="v56218363" class="anchor"></span><div class="para"> <p>U-500 regular</p></div></td><td><span id="v56218365" class="anchor"></span><div class="para"> <p>30 minutes</p></div></td><td><span id="v56218367" class="anchor"></span><div class="para"> <p>4–8 hours</p></div></td><td><span id="v56218369" class="anchor"></span><div class="para"> <p>13–24 hours</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218373" class="anchor"></span><div class="para"> <p>Long-acting</p></div></p></td></tr><tr class="even"><td><span id="v56218376" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Glargine</p></div></td><td><span id="v56218378" class="anchor"></span><div class="para"> <p>3–4 hours</p></div></td><td><span id="v56218380" class="anchor"></span><div class="para"> <p>No peak</p></div></td><td><span id="v56218382" class="anchor"></span><div class="para"> <p>24 hours</p></div></td></tr><tr class="odd"><td><span id="v56218385" class="anchor"></span><div class="para"> <p>U-300 <span class="genericDrug" data-showrollover="false">insulin glargine</span></p></div></td><td><span id="v56218387" class="anchor"></span><div class="para"> <p>6 hours</p></div></td><td><span id="v56218389" class="anchor"></span><div class="para"> <p>No peak</p></div></td><td><span id="v56218391" class="anchor"></span><div class="para"> <p>24 hours</p></div></td></tr><tr class="even"><td><span id="v56218394" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Detemir</p></div></td><td><span id="v56218396" class="anchor"></span><div class="para"> <p>1–2 hours</p></div></td><td><span id="v56218398" class="anchor"></span><div class="para"> <p>No peak</p></div></td><td><span id="v56218400" class="anchor"></span><div class="para"> <p>14–24 hours</p></div></td></tr><tr class="odd"><td><span id="v56218403" class="anchor"></span><div class="para"> <p>Degludec</p></div></td><td><span id="v56218405" class="anchor"></span><div class="para"> <p>1–2 hours</p></div></td><td><span id="v56218407" class="anchor"></span><div class="para"> <p>No peak</p></div></td><td><span id="v56218409" class="anchor"></span><div class="para"> <p>> 40 hours</p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218413" class="anchor"></span><div class="para"> <p>Premixed</p></div></p></td></tr><tr class="odd"><td><span id="v56218416" class="anchor"></span><div class="para"> <p style='padding-left:12px'>70% <span class="genericDrug" data-showrollover="false">Insulin</span> isophane (NPH)/30% regular</p></div></td><td><span id="v56218418" class="anchor"></span><div class="para"> <p>30–60 minutes</p></div></td><td><span id="v56218420" class="anchor"></span><div class="para"> <p>Dual (NPH & regular) </p></div></td><td><span id="v56218422" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="even"><td><span id="x000115" class="anchor"></span><div class="para"> <p>50% <span class="genericDrug" data-showrollover="false">Insulin</span> isophane (NPH)/50% regular</p></div></td><td><span id="x000116" class="anchor"></span><div class="para"> <p>0.5–1 hour</p></div></td><td><span id="x000117" class="anchor"></span><div class="para"> <p>2–12 hours</p></div></td><td><span id="x000118" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="odd"><td><span id="v56218425" class="anchor"></span><div class="para"> <p style='padding-left:12px'>50% Lispro <span class="genericDrug" data-showrollover="false">protamine</span>/50% lispro</p></div></td><td><span id="v56218427" class="anchor"></span><div class="para"> <p>30–60 minutes</p></div></td><td><span id="v56218429" class="anchor"></span><div class="para"> <p>Dual (lispro <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span> & lispro)</p></div></td><td><span id="v56218431" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="even"><td><span id="v56218434" class="anchor"></span><div class="para"> <p style='padding-left:12px'>75% Lispro <span class="genericDrug" data-showrollover="false">protamine</span>/25% lispro</p></div></td><td><span id="v56218436" class="anchor"></span><div class="para"> <p>5–15 minutes</p></div></td><td><span id="v56218438" class="anchor"></span><div class="para"> <p>Dual (lispro <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span> & lispro)</p></div></td><td><span id="v56218440" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="odd"><td><span id="v56218443" class="anchor"></span><div class="para"> <p style='padding-left:12px'>70% Aspart <span class="genericDrug" data-showrollover="false">protamine</span>/30% aspart</p></div></td><td><span id="v56218445" class="anchor"></span><div class="para"> <p>5–15 minutes</p></div></td><td><span id="v56218447" class="anchor"></span><div class="para"> <p>Dual (aspart <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span> & aspart)</p></div></td><td><span id="v56218449" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="even"><td><span id="v56218452" class="anchor"></span><div class="para"> <p>70% Degludec/30% aspart</p></div></td><td><span id="v56218454" class="anchor"></span><div class="para"> <p>15 minutes</p></div></td><td><span id="v56218456" class="anchor"></span><div class="para"> <p>Dual (degludec & aspart)</p></div></td><td><span id="v56218458" class="anchor"></span><div class="para"> <p>> 40 hours</p></div></td></tr></tbody> <tfoot><tr><td colspan="4"><span id="v56218299" class="anchor"></span><div class="para"> <p>* Times are approximate, assume subcutaneous administration, and may vary with injection technique and factors influencing absorption.</p></div></td></tr><tr><td colspan="4"><span id="v56218302" class="anchor"></span><div class="para"> <p>† Lispro and aspart are also available in premixed forms with intermediate-acting <span class="genericDrug" data-showrollover="false">insulins</span>.</p></div></td></tr><tr><td colspan="4"><span id="v56218305" class="anchor"></span><div class="para"> <p>‡ <span class="genericDrug" data-showrollover="false">Insulin</span> isophane also exists in premixed form (<span class="genericDrug" data-showrollover="false">insulin</span> isophane/regular).</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v56218278'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v41829188"></span> <div class="TableFullPage" id="v56218278"> <h3 class="title">Onset, Peak, and Duration of Action of Human Insulin Preparations*</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v56218288" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> Preparation</p></div></th><th style='text-align:left' scope='col'><span id="v56218291" class="anchor"></span><div class="para"> <p>Onset of Action</p></div></th><th style='text-align:left' scope='col'><span id="v56218293" class="anchor"></span><div class="para"> <p>Peak Action</p></div></th><th style='text-align:left' scope='col'><span id="v56218295" class="anchor"></span><div class="para"> <p>Duration of Action</p></div></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218316" class="anchor"></span><div class="para"> <p>Rapid-acting</p></div></p></td></tr><tr class="even"><td><span id="v56218319" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Lispro, aspart, glulisine†</p></div></td><td><span id="v56218321" class="anchor"></span><div class="para"> <p>5–15 minutes</p></div></td><td><span id="v56218323" class="anchor"></span><div class="para"> <p>45–75 minutes</p></div></td><td><span id="v56218325" class="anchor"></span><div class="para"> <p>3–5 hours</p></div></td></tr><tr class="odd"><td><span id="v56218328" class="anchor"></span><div class="para"> <p>Inhaled regular</p></div></td><td><span id="v56218330" class="anchor"></span><div class="para"> <p>< 15=""></p></div></td><td><span id="v56218332" class="anchor"></span><div class="para"> <p>50 minutes</p></div></td><td><span id="v56218334" class="anchor"></span><div class="para"> <p>2–3 hours</p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218338" class="anchor"></span><div class="para"> <p>Short-acting</p></div></p></td></tr><tr class="odd"><td><span id="v56218341" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Regular†</p></div></td><td><span id="v56218343" class="anchor"></span><div class="para"> <p>30–60 minutes</p></div></td><td><span id="v56218345" class="anchor"></span><div class="para"> <p>2–4 hours</p></div></td><td><span id="v56218347" class="anchor"></span><div class="para"> <p>6–8 hours</p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218351" class="anchor"></span><div class="para"> <p>Intermediate-acting</p></div></p></td></tr><tr class="odd"><td><span id="v56218354" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class="genericDrug" data-showrollover="false">Insulin</span> isophane (NPH)‡</p></div></td><td><span id="v56218356" class="anchor"></span><div class="para"> <p>About 2 hours</p></div></td><td><span id="v56218358" class="anchor"></span><div class="para"> <p>4–12 hours</p></div></td><td><span id="v56218360" class="anchor"></span><div class="para"> <p>18–26 hours</p></div></td></tr><tr class="even"><td><span id="v56218363" class="anchor"></span><div class="para"> <p>U-500 regular</p></div></td><td><span id="v56218365" class="anchor"></span><div class="para"> <p>30 minutes</p></div></td><td><span id="v56218367" class="anchor"></span><div class="para"> <p>4–8 hours</p></div></td><td><span id="v56218369" class="anchor"></span><div class="para"> <p>13–24 hours</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218373" class="anchor"></span><div class="para"> <p>Long-acting</p></div></p></td></tr><tr class="even"><td><span id="v56218376" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Glargine</p></div></td><td><span id="v56218378" class="anchor"></span><div class="para"> <p>3–4 hours</p></div></td><td><span id="v56218380" class="anchor"></span><div class="para"> <p>No peak</p></div></td><td><span id="v56218382" class="anchor"></span><div class="para"> <p>24 hours</p></div></td></tr><tr class="odd"><td><span id="v56218385" class="anchor"></span><div class="para"> <p>U-300 <span class="genericDrug" data-showrollover="false">insulin glargine</span></p></div></td><td><span id="v56218387" class="anchor"></span><div class="para"> <p>6 hours</p></div></td><td><span id="v56218389" class="anchor"></span><div class="para"> <p>No peak</p></div></td><td><span id="v56218391" class="anchor"></span><div class="para"> <p>24 hours</p></div></td></tr><tr class="even"><td><span id="v56218394" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Detemir</p></div></td><td><span id="v56218396" class="anchor"></span><div class="para"> <p>1–2 hours</p></div></td><td><span id="v56218398" class="anchor"></span><div class="para"> <p>No peak</p></div></td><td><span id="v56218400" class="anchor"></span><div class="para"> <p>14–24 hours</p></div></td></tr><tr class="odd"><td><span id="v56218403" class="anchor"></span><div class="para"> <p>Degludec</p></div></td><td><span id="v56218405" class="anchor"></span><div class="para"> <p>1–2 hours</p></div></td><td><span id="v56218407" class="anchor"></span><div class="para"> <p>No peak</p></div></td><td><span id="v56218409" class="anchor"></span><div class="para"> <p>> 40 hours</p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218413" class="anchor"></span><div class="para"> <p>Premixed</p></div></p></td></tr><tr class="odd"><td><span id="v56218416" class="anchor"></span><div class="para"> <p style='padding-left:12px'>70% <span class="genericDrug" data-showrollover="false">Insulin</span> isophane (NPH)/30% regular</p></div></td><td><span id="v56218418" class="anchor"></span><div class="para"> <p>30–60 minutes</p></div></td><td><span id="v56218420" class="anchor"></span><div class="para"> <p>Dual (NPH & regular) </p></div></td><td><span id="v56218422" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="even"><td><span id="x000115" class="anchor"></span><div class="para"> <p>50% <span class="genericDrug" data-showrollover="false">Insulin</span> isophane (NPH)/50% regular</p></div></td><td><span id="x000116" class="anchor"></span><div class="para"> <p>0.5–1 hour</p></div></td><td><span id="x000117" class="anchor"></span><div class="para"> <p>2–12 hours</p></div></td><td><span id="x000118" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="odd"><td><span id="v56218425" class="anchor"></span><div class="para"> <p style='padding-left:12px'>50% Lispro <span class="genericDrug" data-showrollover="false">protamine</span>/50% lispro</p></div></td><td><span id="v56218427" class="anchor"></span><div class="para"> <p>30–60 minutes</p></div></td><td><span id="v56218429" class="anchor"></span><div class="para"> <p>Dual (lispro <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span> & lispro)</p></div></td><td><span id="v56218431" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="even"><td><span id="v56218434" class="anchor"></span><div class="para"> <p style='padding-left:12px'>75% Lispro <span class="genericDrug" data-showrollover="false">protamine</span>/25% lispro</p></div></td><td><span id="v56218436" class="anchor"></span><div class="para"> <p>5–15 minutes</p></div></td><td><span id="v56218438" class="anchor"></span><div class="para"> <p>Dual (lispro <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span> & lispro)</p></div></td><td><span id="v56218440" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="odd"><td><span id="v56218443" class="anchor"></span><div class="para"> <p style='padding-left:12px'>70% Aspart <span class="genericDrug" data-showrollover="false">protamine</span>/30% aspart</p></div></td><td><span id="v56218445" class="anchor"></span><div class="para"> <p>5–15 minutes</p></div></td><td><span id="v56218447" class="anchor"></span><div class="para"> <p>Dual (aspart <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span> & aspart)</p></div></td><td><span id="v56218449" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="even"><td><span id="v56218452" class="anchor"></span><div class="para"> <p>70% Degludec/30% aspart</p></div></td><td><span id="v56218454" class="anchor"></span><div class="para"> <p>15 minutes</p></div></td><td><span id="v56218456" class="anchor"></span><div class="para"> <p>Dual (degludec & aspart)</p></div></td><td><span id="v56218458" class="anchor"></span><div class="para"> <p>> 40 hours</p></div></td></tr></tbody> <tfoot><tr><td colspan="4"><span id="v56218299" class="anchor"></span><div class="para"> <p>* Times are approximate, assume subcutaneous administration, and may vary with injection technique and factors influencing absorption.</p></div></td></tr><tr><td colspan="4"><span id="v56218302" class="anchor"></span><div class="para"> <p>† Lispro and aspart are also available in premixed forms with intermediate-acting <span class="genericDrug" data-showrollover="false">insulins</span>.</p></div></td></tr><tr><td colspan="4"><span id="v56218305" class="anchor"></span><div class="para"> <p>‡ <span class="genericDrug" data-showrollover="false">Insulin</span> isophane also exists in premixed form (<span class="genericDrug" data-showrollover="false">insulin</span> isophane/regular).</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v56218278'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v41829188"></span> <div class="TableFullPage" id="v56218278"> <h3 class="title">Onset, Peak, and Duration of Action of Human Insulin Preparations*</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v56218288" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> Preparation</p></div></th><th style='text-align:left' scope='col'><span id="v56218291" class="anchor"></span><div class="para"> <p>Onset of Action</p></div></th><th style='text-align:left' scope='col'><span id="v56218293" class="anchor"></span><div class="para"> <p>Peak Action</p></div></th><th style='text-align:left' scope='col'><span id="v56218295" class="anchor"></span><div class="para"> <p>Duration of Action</p></div></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218316" class="anchor"></span><div class="para"> <p>Rapid-acting</p></div></p></td></tr><tr class="even"><td><span id="v56218319" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Lispro, aspart, glulisine†</p></div></td><td><span id="v56218321" class="anchor"></span><div class="para"> <p>5–15 minutes</p></div></td><td><span id="v56218323" class="anchor"></span><div class="para"> <p>45–75 minutes</p></div></td><td><span id="v56218325" class="anchor"></span><div class="para"> <p>3–5 hours</p></div></td></tr><tr class="odd"><td><span id="v56218328" class="anchor"></span><div class="para"> <p>Inhaled regular</p></div></td><td><span id="v56218330" class="anchor"></span><div class="para"> <p>< 15=""></p></div></td><td><span id="v56218332" class="anchor"></span><div class="para"> <p>50 minutes</p></div></td><td><span id="v56218334" class="anchor"></span><div class="para"> <p>2–3 hours</p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218338" class="anchor"></span><div class="para"> <p>Short-acting</p></div></p></td></tr><tr class="odd"><td><span id="v56218341" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Regular†</p></div></td><td><span id="v56218343" class="anchor"></span><div class="para"> <p>30–60 minutes</p></div></td><td><span id="v56218345" class="anchor"></span><div class="para"> <p>2–4 hours</p></div></td><td><span id="v56218347" class="anchor"></span><div class="para"> <p>6–8 hours</p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218351" class="anchor"></span><div class="para"> <p>Intermediate-acting</p></div></p></td></tr><tr class="odd"><td><span id="v56218354" class="anchor"></span><div class="para"> <p style='padding-left:12px'><span class="genericDrug" data-showrollover="false">Insulin</span> isophane (NPH)‡</p></div></td><td><span id="v56218356" class="anchor"></span><div class="para"> <p>About 2 hours</p></div></td><td><span id="v56218358" class="anchor"></span><div class="para"> <p>4–12 hours</p></div></td><td><span id="v56218360" class="anchor"></span><div class="para"> <p>18–26 hours</p></div></td></tr><tr class="even"><td><span id="v56218363" class="anchor"></span><div class="para"> <p>U-500 regular</p></div></td><td><span id="v56218365" class="anchor"></span><div class="para"> <p>30 minutes</p></div></td><td><span id="v56218367" class="anchor"></span><div class="para"> <p>4–8 hours</p></div></td><td><span id="v56218369" class="anchor"></span><div class="para"> <p>13–24 hours</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218373" class="anchor"></span><div class="para"> <p>Long-acting</p></div></p></td></tr><tr class="even"><td><span id="v56218376" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Glargine</p></div></td><td><span id="v56218378" class="anchor"></span><div class="para"> <p>3–4 hours</p></div></td><td><span id="v56218380" class="anchor"></span><div class="para"> <p>No peak</p></div></td><td><span id="v56218382" class="anchor"></span><div class="para"> <p>24 hours</p></div></td></tr><tr class="odd"><td><span id="v56218385" class="anchor"></span><div class="para"> <p>U-300 <span class="genericDrug" data-showrollover="false">insulin glargine</span></p></div></td><td><span id="v56218387" class="anchor"></span><div class="para"> <p>6 hours</p></div></td><td><span id="v56218389" class="anchor"></span><div class="para"> <p>No peak</p></div></td><td><span id="v56218391" class="anchor"></span><div class="para"> <p>24 hours</p></div></td></tr><tr class="even"><td><span id="v56218394" class="anchor"></span><div class="para"> <p style='padding-left:12px'>Detemir</p></div></td><td><span id="v56218396" class="anchor"></span><div class="para"> <p>1–2 hours</p></div></td><td><span id="v56218398" class="anchor"></span><div class="para"> <p>No peak</p></div></td><td><span id="v56218400" class="anchor"></span><div class="para"> <p>14–24 hours</p></div></td></tr><tr class="odd"><td><span id="v56218403" class="anchor"></span><div class="para"> <p>Degludec</p></div></td><td><span id="v56218405" class="anchor"></span><div class="para"> <p>1–2 hours</p></div></td><td><span id="v56218407" class="anchor"></span><div class="para"> <p>No peak</p></div></td><td><span id="v56218409" class="anchor"></span><div class="para"> <p>> 40 hours</p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56218413" class="anchor"></span><div class="para"> <p>Premixed</p></div></p></td></tr><tr class="odd"><td><span id="v56218416" class="anchor"></span><div class="para"> <p style='padding-left:12px'>70% <span class="genericDrug" data-showrollover="false">Insulin</span> isophane (NPH)/30% regular</p></div></td><td><span id="v56218418" class="anchor"></span><div class="para"> <p>30–60 minutes</p></div></td><td><span id="v56218420" class="anchor"></span><div class="para"> <p>Dual (NPH & regular) </p></div></td><td><span id="v56218422" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="even"><td><span id="x000115" class="anchor"></span><div class="para"> <p>50% <span class="genericDrug" data-showrollover="false">Insulin</span> isophane (NPH)/50% regular</p></div></td><td><span id="x000116" class="anchor"></span><div class="para"> <p>0.5–1 hour</p></div></td><td><span id="x000117" class="anchor"></span><div class="para"> <p>2–12 hours</p></div></td><td><span id="x000118" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="odd"><td><span id="v56218425" class="anchor"></span><div class="para"> <p style='padding-left:12px'>50% Lispro <span class="genericDrug" data-showrollover="false">protamine</span>/50% lispro</p></div></td><td><span id="v56218427" class="anchor"></span><div class="para"> <p>30–60 minutes</p></div></td><td><span id="v56218429" class="anchor"></span><div class="para"> <p>Dual (lispro <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span> & lispro)</p></div></td><td><span id="v56218431" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="even"><td><span id="v56218434" class="anchor"></span><div class="para"> <p style='padding-left:12px'>75% Lispro <span class="genericDrug" data-showrollover="false">protamine</span>/25% lispro</p></div></td><td><span id="v56218436" class="anchor"></span><div class="para"> <p>5–15 minutes</p></div></td><td><span id="v56218438" class="anchor"></span><div class="para"> <p>Dual (lispro <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span> & lispro)</p></div></td><td><span id="v56218440" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="odd"><td><span id="v56218443" class="anchor"></span><div class="para"> <p style='padding-left:12px'>70% Aspart <span class="genericDrug" data-showrollover="false">protamine</span>/30% aspart</p></div></td><td><span id="v56218445" class="anchor"></span><div class="para"> <p>5–15 minutes</p></div></td><td><span id="v56218447" class="anchor"></span><div class="para"> <p>Dual (aspart <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>protamine</span> & aspart)</p></div></td><td><span id="v56218449" class="anchor"></span><div class="para"> <p>10–16 hours</p></div></td></tr><tr class="even"><td><span id="v56218452" class="anchor"></span><div class="para"> <p>70% Degludec/30% aspart</p></div></td><td><span id="v56218454" class="anchor"></span><div class="para"> <p>15 minutes</p></div></td><td><span id="v56218456" class="anchor"></span><div class="para"> <p>Dual (degludec & aspart)</p></div></td><td><span id="v56218458" class="anchor"></span><div class="para"> <p>> 40 hours</p></div></td></tr></tbody> <tfoot><tr><td colspan="4"><span id="v56218299" class="anchor"></span><div class="para"> <p>* Times are approximate, assume subcutaneous administration, and may vary with injection technique and factors influencing absorption.</p></div></td></tr><tr><td colspan="4"><span id="v56218302" class="anchor"></span><div class="para"> <p>† Lispro and aspart are also available in premixed forms with intermediate-acting <span class="genericDrug" data-showrollover="false">insulins</span>.</p></div></td></tr><tr><td colspan="4"><span id="v56218305" class="anchor"></span><div class="para"> <p>‡ <span class="genericDrug" data-showrollover="false">Insulin</span> isophane also exists in premixed form (<span class="genericDrug" data-showrollover="false">insulin</span> isophane/regular).</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v84915273'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v84915274"></span> <div class="TableFullPage" id="v84915273"> <h3 class="title">Characteristics of Oral Antihyperglycemics</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v84915282" class="anchor"></span><div class="para"> <p>Generic Name</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v84915285" class="anchor"></span><div class="para"> <p>Comments</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915305" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> secretagogues: Long-acting (sulfonylureas)</p></div></p></td><td><span id="v84915308" class="anchor"></span><div class="para"> <p>Augment pancreatic beta-cell <span class="genericDrug" data-showrollover="false">insulin</span> secretion</p></div><span id="v84915310" class="anchor"></span><div class="para"> <p>Can be used alone or in combination with <span class="genericDrug" data-showrollover="false">insulin</span> and other medications</p></div><span id="v84915312" class="anchor"></span><div class="para"> <p>Their long duration of action may lead to serious hypoglycemia, especially in older patients</p></div><span id="v84915313" class="anchor"></span><div class="para"> <p>Efficacy may wane after 5 years of use</p></div></td></tr><tr class="even"><td><span id="v84915316" class="anchor"></span><div class="para"> <p>Acetohexamide*</p></div></td><td><span id="v84915318" class="anchor"></span><div class="para"> <p>Not available in the United States</p></div></td></tr><tr class="odd"><td><span id="v84915321" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chlorpropamide</span>*</p></div></td><td><span id="v84915323" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Chlorpropamide</span>: May cause <a href="./{ED55B7A6-31FA-4DD1-B5C1-FA91E08A131D}.html" data-toggle="tooltip" title="Hyponatremia" data-id="c28133ec-5b43-45ff-82a7-73f56b9d50b3" data-itemid="ed55b7a6-31fa-4dd1-b5c1-fa91e08a131d">hyponatremia</a><span id="c28133ec-5b43-45ff-82a7-73f56b9d50b3" class="d-none xref"> <span class="tooltip-container"> <a href="./{ED55B7A6-31FA-4DD1-B5C1-FA91E08A131D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hyponatremia </span> Hyponatremia is decrease in serum sodium concentration < 136 mEq/L (< 136 mmol/L) caused by an excess of water relative to solute. Common causes include diuretic use, diarrhea, heart failure... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and flushing after <span class="genericDrug" data-showrollover="false">alcohol</span> ingestion</p></div></td></tr><tr class="even"><td><span id="v84915328" class="anchor"></span><div class="para"> <p>Tolazamide*</p></div></td><td><span id="v84915330" class="anchor"></span><div class="para"> <p>Not available in the United States</p></div></td></tr><tr class="odd"><td><span id="v84915333" class="anchor"></span><div class="para"> <p>Tolbutamide*</p></div></td><td><span id="v84915335" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915338" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Glyburide</span>, regular-release†</p></div></td><td><span id="v84915340" class="anchor"></span><div class="para"> <p>No evidence of increased effectiveness of doses > 10 mg/day</p></div></td></tr><tr class="odd"><td><span id="v84915343" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Glyburide</span>, micronized†</p></div></td><td><span id="v84915345" class="anchor"></span><div class="para"> <p> No evidence of increased effectiveness of doses > 10 mg/day</p></div></td></tr><tr class="even"><td><span id="v84915348" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Glipizide</span>, regular-release†</p></div></td><td><span id="v84915350" class="anchor"></span><div class="para"> <p> No evidence of increased effectiveness of doses > 10 mg/day</p></div></td></tr><tr class="odd"><td><span id="v84915353" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Glipizide</span>, extended-release†</p></div></td><td><span id="v84915355" class="anchor"></span><div class="para"> <p> No evidence of increased effectiveness of doses > 10 mg/day</p></div></td></tr><tr class="even"><td><span id="v84915358" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Glimepiride</span>†</p></div></td><td><span id="v84915360" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915364" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> secretagogues: Short-acting (meglitinides)</p></div></p></td><td><span id="v84915367" class="anchor"></span><div class="para"> <p>Augment pancreatic beta-cell <span class="genericDrug" data-showrollover="false">insulin</span> secretion</p></div><span id="v84915369" class="anchor"></span><div class="para"> <p>Can be used alone or in combination with other oral medications and <span class="genericDrug" data-showrollover="false">insulin</span></p></div></td></tr><tr class="even"><td><span id="v84915373" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Nateglinide</span></p></div></td><td><span id="v84915375" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd"><td><span id="v84915378" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Repaglinide</span></p></div></td><td><span id="v84915380" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even" tablehead2=""><td><p class="tableHead2"><span id="v84915384" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> sensitizers: Biguanides</p></div></p></td><td><span id="v84915387" class="anchor"></span><div class="para"> <p>Augment suppression of hepatic glucose production by <span class="genericDrug" data-showrollover="false">insulin</span></p></div><span id="v84915389" class="anchor"></span><div class="para"> <p>Can be used alone or in combination with other oral medications and <span class="genericDrug" data-showrollover="false">insulin</span></p></div><span id="v84915391" class="anchor"></span><div class="para"> <p>Major adverse effects: <a href="./{D14FD7DA-5C9F-4CC9-B0CC-F79C4E61D23E}.html" data-toggle="tooltip" title="Lactic Acidosis" data-id="0e560814-c89f-4b9c-90de-e9f03e691278" data-itemid="d14fd7da-5c9f-4cc9-b0cc-f79c4e61d23e">Lactic acidosis</a><span id="0e560814-c89f-4b9c-90de-e9f03e691278" class="d-none xref"> <span class="tooltip-container"> <a href="./{D14FD7DA-5C9F-4CC9-B0CC-F79C4E61D23E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Lactic Acidosis </span> Lactic acidosis is a high anion gap metabolic acidosis due to elevated blood lactate. Lactic acidosis results from overproduction of lactate, decreased metabolism of lactate, or both. (See also... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (rare)</p></div><span id="v84915393" class="anchor"></span><div class="para"> <p>Contraindicated in at-risk patients, including those with renal insufficiency, metabolic acidosis, hypoxia, alcohol use disorder, or dehydration</p></div><span id="v84915394" class="anchor"></span><div class="para"> <p>Do not cause hypoglycemia</p></div><span id="v84915395" class="anchor"></span><div class="para"> <p>Other adverse effects: Gastrointestinal distress (diarrhea, nausea, pain), <span class="genericDrug" data-showrollover="false">vitamin B12</span> malabsorption</p></div><span id="v84915397" class="anchor"></span><div class="para"> <p>Potentiate weight loss</p></div><span id="v84915398" class="anchor"></span><div class="para"> <p>Should be stopped temporarily before radiologic procedures requiring use of contrast agents</p></div></td></tr><tr class="odd"><td><span id="v84915401" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Metformin</span>, regular-release</p></div></td><td><span id="v84915403" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915406" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Metformin</span>, extended-release</p></div></td><td><span id="v84915408" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915412" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Insulin</span> sensitizers: Thiazolidinediones</p></div></p></td><td><span id="v84915415" class="anchor"></span><div class="para"> <p>Augment suppression of hepatic glucose production by <span class="genericDrug" data-showrollover="false">insulin</span> and increase <span class="genericDrug" data-showrollover="false">insulin</span> sensitivity in muscle and adipose tissue</p></div><span id="v84915418" class="anchor"></span><div class="para"> <p>Can be used alone or in combination with other oral medications and <span class="genericDrug" data-showrollover="false">insulin</span></p></div><span id="v84915420" class="anchor"></span><div class="para"> <p>Major adverse effects: Weight gain, fluid retention, anemia (mild)</p></div><span id="v84915421" class="anchor"></span><div class="para"> <p>Hepatotoxicity rare, but liver monitoring required</p></div></td></tr><tr class="even"><td><span id="v84915424" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pioglitazone</span></p></div></td><td><span id="v84915426" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Pioglitazone</span>: May increase risk of bladder cancer, heart failure, and fractures</p></div></td></tr><tr class="odd"><td><span id="v84915430" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rosiglitazone</span></p></div></td><td><span id="v84915432" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Rosiglitazone</span>: May increase low-density lipoprotein cholesterol and may increase risk of heart failure, angina, myocardial infarction, stroke, and fractures</p></div></td></tr><tr class="even" tablehead2=""><td><p class="tableHead2"><span id="v84915437" class="anchor"></span><div class="para"> <p>Alpha-glucosidase inhibitors</p></div></p></td><td><span id="v84915439" class="anchor"></span><div class="para"> <p>Intestinal enzyme inhibitors</p></div><span id="v84915440" class="anchor"></span><div class="para"> <p>Used as monotherapy or combination therapy with other oral medications or <span class="genericDrug" data-showrollover="false">insulin</span> to decrease postprandial plasma glucose levels</p></div><span id="v84915442" class="anchor"></span><div class="para"> <p>Must be taken with the first bite of meal</p></div><span id="v84915443" class="anchor"></span><div class="para"> <p>Gastrointestinal adverse effects (flatulence, diarrhea, bloating) common but may decrease over time</p></div><span id="v84915444" class="anchor"></span><div class="para"> <p>Start with small dose (25 mg/day) and gradually titrate over several weeks</p></div></td></tr><tr class="odd"><td><span id="v84915447" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Acarbose</span></p></div></td><td><span id="v84915449" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915452" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Miglitol</span></p></div></td><td><span id="v84915454" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915458" class="anchor"></span><div class="para"> <p>Dipeptidyl peptidase-4 (DPP4) inhibitors</p></div></p></td><td><span id="v84915460" class="anchor"></span><div class="para"> <p>Inhibit the enzyme DPP-4, which is involved in the breakdown of GLP-1, a peptide that stimulates <span class="genericDrug" data-showrollover="false">insulin</span> secretion and inhibits <span class="genericDrug" data-showrollover="false">glucagon</span> secretion</p></div><span id="v84915463" class="anchor"></span><div class="para"> <p>All DPP-4 inhibitors can be used in moderate to severe renal insufficiency. All except <span class="genericDrug" data-showrollover="false">linagliptin</span> require dose adjustment for estimated glomerular filtration rate</p></div><span id="v84915465" class="anchor"></span><div class="para"> <p>Well-tolerated but cause only modest improvements in hemoglobin A1C </p></div><span id="v84915466" class="anchor"></span><div class="para"> <p>A slight increase in risk of pancreatitis </p></div></td></tr><tr class="even"><td><span id="v84915469" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Alogliptin</span> </p></div></td><td><span id="v84915471" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd"><td><span id="v84915474" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Linagliptin</span></p></div></td><td><span id="v84915476" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915479" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Saxagliptin</span></p></div></td><td><span id="v84915481" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd"><td><span id="v84915484" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Sitagliptin</span></p></div></td><td><span id="v84915486" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even" tablehead2=""><td><p class="tableHead2"><span id="v84915490" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Glucagon</span>-like peptide-1 (GLP-1) receptor agonists‡</p></div></p></td><td><span id="v84915493" class="anchor"></span><div class="para"> <p>Mimic the effects of GLP-1, a peptide made in the small intestine that enhances glucose-dependent <span class="genericDrug" data-showrollover="false">insulin</span> secretion</p></div></td></tr><tr class="odd"><td><span id="v84915497" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Semaglutide</span>¶</p></div></td><td><span id="v84915499" class="anchor"></span><div class="para"> <p>Low risk of hypoglycemia; may promote modest weight loss</p></div><span id="v84915500" class="anchor"></span><div class="para"> <p>Increased risk of pancreatitis</p></div><span id="v84915501" class="anchor"></span><div class="para"> <p>Thyroid C-cell tumors (medullary carcinoma) noted in rodents</p></div><span id="v84915502" class="anchor"></span><div class="para"> <p>Weekly subcutaneous preparations may cause fewer gastrointestinal adverse effects. When given once or twice a day, lowest starting dose may minimize nausea</p></div><span id="v84915503" class="anchor"></span><div class="para"> <p>Oral <span class="genericDrug" data-showrollover="false">semaglutide</span> may decrease cardiovascular death in patients with high risk of cardiovascular disease </p></div><span id="v84915505" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Semaglutide</span> is associated with increased progression of diabetic retinopathy</p></div></td></tr><tr class="even" tablehead2=""><td><p class="tableHead2"><span id="v84915510" class="anchor"></span><div class="para"> <p>Sodium-glucose co-transporter 2 (SGLT2) inhibitors</p></div></p></td><td><span id="v84915512" class="anchor"></span><div class="para"> <p>Inhibit SGLT-2 in the proximal tubule of the kidney, which blocks glucose reabsorption, thus causing glycosuria</p></div><span id="v84915513" class="anchor"></span><div class="para"> <p>SGLT-2 inhibitors may cause Fournier gangrene, weight loss, orthostatic hypotension, yeast infections, and urinary tract infections </p></div><span id="v84915514" class="anchor"></span><div class="para"> <p>Use cautiously in older adults and in patients with renal impairment </p></div><span id="v84915515" class="anchor"></span><div class="para"> <p>Associated with euglycemic diabetic ketoacidosis. Ketogenic, or low-carbohydrate, diets should be avoided and medications should be stopped several days before procedures or during illness and inability to tolerate oral intake </p></div></td></tr><tr class="odd"><td><span id="v84915518" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Bexagliflozin</span></p></div></td><td><span id="v84915520" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915523" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Canagliflozin</span></p></div></td><td><span id="v84915525" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Canagliflozin</span> is associated with a higher rate of limb amputations </p></div><span id="v84915527" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Canagliflozin</span> decreases mortality and heart failure hospitalizations in patients with cardiovascular risk. Decreases progression of chronic kidney disease </p></div></td></tr><tr class="odd"><td><span id="v84915531" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dapagliflozin</span></p></div></td><td><span id="v84915533" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Dapagliflozin</span> decreases mortality and heart failure hospitalizations in patients with cardiovascular risk. Decreases progression of chronic kidney disease</p></div></td></tr><tr class="even"><td><span id="v84915537" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Empagliflozin</span></p></div></td><td><span id="v84915539" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Empagliflozin</span> decreases mortality and heart failure hospitalizations in patients with cardiovascular risk. Decreases progression of chronic kidney disease</p></div></td></tr><tr class="odd"><td><span id="v84915543" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Ertugliflozin</span></p></div></td><td><span id="v84915545" class="anchor"></span><div class="para"> <p>—</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v84915289" class="anchor"></span><div class="para"> <p>* First-generation sulfonylureas.</p></div></td></tr><tr><td colspan="2"><span id="v84915292" class="anchor"></span><div class="para"> <p>† 2nd-generation sulfonylureas.</p></div></td></tr><tr><td colspan="2"><span id="v84915295" class="anchor"></span><div class="para"> <p>‡ See table <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84915548" data-toggle="tooltip" title="Characteristics of Injectable Non- Antihyperglycemic Medications" data-id="1b48a7db-5d49-4a71-9c41-103f7e6dd805" data-itemid="912a66b5-650e-4099-a978-4c78e044364d">Characteristics of Injectable Non-<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Insulin</span> Antihyperglycemic Medications</a><span id="1b48a7db-5d49-4a71-9c41-103f7e6dd805" class="d-none xref"> <span class="tooltip-container"> <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84915548"> <span class="tooltip-content"> <span class="tooltip-heading"> Characteristics of Injectable Non- Antihyperglycemic Medications </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="/Content/Images/Redesign/table/icon_table_red.png?mh=160&mw=160" class="tooltip-Preview" alt="Characteristics of Injectable Non- Antihyperglycemic Medications" loading="lazy"> </span> </a> </span> </span> for information on injectable <span class="genericDrug" data-showrollover="false">glucagon</span>-like peptide-1 (GLP-1) receptor agonists.</p></div></td></tr><tr><td colspan="2"><span id="v84915300" class="anchor"></span><div class="para"> <p>¶ Also available in an injectable form. </p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v84915547'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v84915548"></span> <div class="TableFullPage" id="v84915547"> <h3 class="title">Characteristics of Injectable Non- Antihyperglycemic Medications</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v84915556" class="anchor"></span><div class="para"> <p>Generic Name</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v84915559" class="anchor"></span><div class="para"> <p>Comments</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915572" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Glucagon</span>-like peptide-1 (GLP-1) agonists</p></div></p></td><td><span id="v84915575" class="anchor"></span><div class="para"> <p>Low risk of hypoglycemia; may promote modest weight loss</p></div><span id="v84915576" class="anchor"></span><div class="para"> <p>Increased risk of pancreatitis</p></div><span id="v84915577" class="anchor"></span><div class="para"> <p>Thyroid C-cell tumors (medullary carcinoma) noted in rodents</p></div><span id="v84915578" class="anchor"></span><div class="para"> <p>To minimize nausea and vomiting, start at the lowest dose and titrate according to manufacturer's recommendations </p></div><span id="v84915579" class="anchor"></span><div class="para"> <p>May improve hepatic fat content and fibrosis, MASLD, and MASH</p></div></td></tr><tr class="even"><td><span id="v84915582" class="anchor"></span><div class="para"> <p>Albiglutide</p></div></td><td><span id="v84915584" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd"><td><span id="v84915587" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Dulaglutide</span> </p></div></td><td><span id="v84915589" class="anchor"></span><div class="para"> <p>May decrease major adverse cardiovascular events in patients with high risk of cardiovascular disease</p></div></td></tr><tr class="even"><td><span id="v84915592" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Exenatide</span></p></div></td><td><span id="v84915594" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="odd"><td><span id="v84915597" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Exenatide</span>, once a week</p></div></td><td><span id="v84915599" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915602" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Liraglutide</span></p></div></td><td><span id="v84915604" class="anchor"></span><div class="para"> <p>May decrease major adverse cardiovascular events and cardiovascular death in patients with high risk of cardiovascular disease</p></div></td></tr><tr class="odd"><td><span id="v84915607" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lixisenatide</span></p></div></td><td><span id="v84915609" class="anchor"></span><div class="para"> <p>—</p></div></td></tr><tr class="even"><td><span id="v84915612" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Semaglutide</span>*</p></div></td><td><span id="v84915614" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Semaglutide</span> is associated with increased progression of diabetic retinopathy</p></div><span id="v84915616" class="anchor"></span><div class="para"> <p>May decrease major adverse cardiovascular events and cardiovascular death (oral <span class="genericDrug" data-showrollover="false">semaglutide</span>) in patients with high risk of cardiovascular disease</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915621" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Amylin</span> analog</p></div></p></td><td><span id="v84915624" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v84915627" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pramlintide</span></p></div></td><td><span id="v84915629" class="anchor"></span><div class="para"> <p>For use in combination with <span class="genericDrug" data-showrollover="false">insulin</span>, but injected using a separate syringe</p></div><span id="v84915631" class="anchor"></span><div class="para"> <p>May need to adjust <span class="genericDrug" data-showrollover="false">insulin</span> dose to avoid hypoglycemia</p></div><span id="v84915633" class="anchor"></span><div class="para"> <p>Nausea common but declining with time</p></div><span id="v84915634" class="anchor"></span><div class="para"> <p>May promote modest weight loss</p></div></td></tr><tr class="odd" tablehead2=""><td><p class="tableHead2"><span id="v84915638" class="anchor"></span><div class="para"> <p>Dual incretin agonists (glucose-dependent insulinotropic polypeptide (GIP)/<span class="genericDrug" data-showrollover="false">glucagon</span>-like peptide-1 (GLP-1) receptor agonist</p></div></p></td><td><span id="v84915640" class="anchor"></span><div class="para"> <p></div></td></tr><tr class="even"><td><span id="v84915643" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tirzepatide</span></p></div></td><td><span id="v84915645" class="anchor"></span><div class="para"> <p>Promotes weight loss</p></div><span id="v84915646" class="anchor"></span><div class="para"> <p>Causes GI symptoms, including decreased appetite, diarrhea , nausea, abdominal pain and increased amylase and lipase</p></div><span id="v84915647" class="anchor"></span><div class="para"> <p>To minimize symptoms start at lowest dose and titrate according to manufacturers recommendations</p></div><span id="v84915648" class="anchor"></span><div class="para"> <p>Thyroid C cell tumors noted in rodents</p></div><span id="v84915649" class="anchor"></span><div class="para"> <p>Cases of pancreatitis have been reported</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v84915563" class="anchor"></span><div class="para"> <p>* Also available in an oral form. See table <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84915274" data-toggle="tooltip" title="Characteristics of Oral Antihyperglycemics" data-id="01b05f51-77f0-4493-908b-b04db5a9b208" data-itemid="912a66b5-650e-4099-a978-4c78e044364d">Characteristics of Oral Antihyperglycemics</a><span id="01b05f51-77f0-4493-908b-b04db5a9b208" class="d-none xref"> <span class="tooltip-container"> <a href="./{912A66B5-650E-4099-A978-4C78E044364D}.html#v84915274"> <span class="tooltip-content"> <span class="tooltip-heading"> Characteristics of Oral Antihyperglycemics </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="/Content/Images/Redesign/table/icon_table_red.png?mh=160&mw=160" class="tooltip-Preview" alt="Characteristics of Oral Antihyperglycemics" loading="lazy"> </span> </a> </span> </span> for information.</p></div></td></tr><tr><td colspan="2"><span id="v84915567" class="anchor"></span><div class="para"> <p>GI <span class='symbol'>=</span> gastrointestinal; MASLD <span class='symbol'>=</span> metabolic dysfunction-associated steatotic liver disease; MASH <span class='symbol'>=</span> metabolic dysfunction-associated steatohepatitis.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55564932'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v21454021"></span> <div class="TableFullPage" id="v55564932"> <h3 class="title">Statins For ASCVD Prevention</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v55564942" class="anchor"></span><div class="para"> <p>Classification</p></div></th><th style='text-align:left' scope='col'><span id="v55564944" class="anchor"></span><div class="para"> <p>Effects*</p></div></th><th style='text-align:left' scope='col'><span id="v55564946" class="anchor"></span><div class="para"> <p>Recommended For</p></div></th><th style='text-align:left' scope='col'><span id="v55564948" class="anchor"></span><div class="para"> <p>Examples†</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v55564966" class="anchor"></span><div class="para"> <p>High-intensity</p></div></td><td><span id="v55564968" class="anchor"></span><div class="para"> <p>Lowers LDL-C ≥ 50%</p></div></td><td><span id="v55564970" class="anchor"></span><div class="para"> <p>Clinical ASCVD, age ≤ 75 years</p></div><span id="v55564971" class="anchor"></span><div class="para"> <p>LDL-C ≥ 190 mg/dL (4.9 mmol/L)</p></div><span id="v55564973" class="anchor"></span><div class="para"> <p>Age 40 to 75 years, 10-year ASCVD risk ≥ 7.5%</p></div><span id="v55564972" class="anchor"></span><div class="para"> <p>Diabetes and 10-year ASCVD risk ≥ 7.5%</p></div></td><td><span id="v55564976" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atorvastatin</span> 40-80 mg</p></div><span id="v55564977" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rosuvastatin</span> 20-40 mg</p></div></td></tr><tr class="even"><td><span id="v55564980" class="anchor"></span><div class="para"> <p>Moderate-intensity</p></div></td><td><span id="v55564982" class="anchor"></span><div class="para"> <p>Lowers LDL-C 30 to <></p></div></td><td><span id="v55564984" class="anchor"></span><div class="para"> <p>Clinical ASCVD, age > 75 years</p></div><span id="v55564987" class="anchor"></span><div class="para"> <p>Age 40 to 75 years, 10-year ASCVD risk 5 to <></p></div><span id="v55564986" class="anchor"></span><div class="para"> <p>Age 40 to 75 years, 10-year ASCVD risk ≥ 7.5% (if unable to tolerate high-intensity statin)</p></div><span id="v55564985" class="anchor"></span><div class="para"> <p>Diabetes and 10-year ASCVD risk <></p></div></td><td><span id="v55564989" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atorvastatin</span> 10-20 mg</p></div><span id="v55564990" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fluvastatin</span> XL 80 mg</p></div><span id="v55564991" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lovastatin</span> 40 mg</p></div><span id="v55564992" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pitavastatin</span> 2-4 mg</p></div><span id="v55564993" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pravastatin</span> 40-80 mg</p></div><span id="v55564994" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Rosuvastatin</span> 5-10 mg</p></div><span id="v55564995" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Simvastatin</span> 20-40 mg</p></div></td></tr><tr class="odd"><td><span id="v55564998" class="anchor"></span><div class="para"> <p>Low-intensity</p></div></td><td><span id="v55565000" class="anchor"></span><div class="para"> <p>Lowers LDL-C <></p></div></td><td><span id="v55565002" class="anchor"></span><div class="para"> <p>Patients who cannot tolerate high or moderate intensity treatment </p></div></td><td><span id="v55565004" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Fluvastatin</span> 20-40 mg</p></div><span id="v55565005" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Lovastatin</span> 20 mg</p></div><span id="v55565006" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pitavastatin</span> 1 mg</p></div><span id="v55565007" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pravastatin</span> 10-20 mg</p></div></td></tr></tbody> <tfoot><tr><td colspan="4"><span id="v55564952" class="anchor"></span><div class="para"> <p>* Individual response may vary.</p></div></td></tr><tr><td colspan="4"><span id="v55564955" class="anchor"></span><div class="para"> <p>† All doses are oral and given once daily.</p></div></td></tr><tr><td colspan="4"><span id="v55564958" class="anchor"></span><div class="para"> <p>ASCVD = atherosclerotic cardiovascular disease; LDL-C = low density lipoprotein cholesterol.</p></div></td></tr><tr><td colspan="4"><span id="v55564961" class="anchor"></span><div class="para"> <p>Adapted from Stone NJ, Robinson J, Lichtenstein AH, et al: 2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. <i>Circulation</i> 129:S1–S45, 2014.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>